HUMAN SKELETAL MUSCLE MITOCHONDRIA: 

CHANGES WITH AGING AND ROLE IN SARCOPENIA by Distefano, Giovanna
 HUMAN SKELETAL MUSCLE MITOCHONDRIA:  
CHANGES WITH AGING AND ROLE IN SARCOPENIA 
 
 
 
 
 
 
 
by 
Giovanna Distefano 
BS in Physical Therapy, Universidade Metodista de Piracicaba, UNIMEP, 2005 
MSc in Muscular Plasticity, Universidade Metodista de Piracicaba, UNIMEP, 2007 
  
 
 
 
 
 
 
 
 
Submitted to the Graduate Faculty of 
School of Health and Rehabilitation Sciences in partial fulfillment  
of the requirements for the degree of 
Doctor of Philosophy 
 
 
 
 
 
 
 
 
 
University of Pittsburgh 
2015 
 
ii 
UNIVERSITY OF PITTSBURGH 
SCHOOL OF HEALTH AND REHABILITATION SCIENCES 
 
 
 
 
 
 
 
 
This dissertation was presented 
 
by 
 
 
Giovanna Distefano 
 
 
 
It was defended on 
December 7, 2015 
and approved by 
Committee Chair: Dr. Michael L. Boninger, Professor, School of Medicine  
Research Mentor: Dr. Bret H. Goodpaster, Professor, Translational Research Institute for 
Metabolism and Diabetes, Florida Hospital 
Dr. Sara R. Piva, Associate Professor, School of Health and Rehabilitation Science  
Dr. Fabrisia Ambrosio, Assistant Professor, School of Medicine  
Dr. Anne B. Newman, Professor, Graduate School of Public Health 
  
 
 
iii 
Copyright © by Giovanna Distefano 
2015 
iv 
HUMAN SKELETAL MUSCLE MITOCHONDRIA: 
CHANGES WITH AGING AND ROLE IN SARCOPENIA 
 
 
Giovanna Distefano, PhD 
 
 
University of Pittsburgh, 2015 
 
 
 
Sarcopenia, the age-related progressive loss of muscle mass, strength and physical function, is a 
well-established risk factor for several negative health-related conditions. While cellular, systemic 
and lifestyle factors have shown to be associated with the onset and development of sarcopenia, 
the primary mechanisms contributing to this process are still uncertain, especially in humans. 
Among the cellular factors hypothesized to play a role on muscle aging is mitochondrial function. 
Several questions, however, remain. The purpose of study 1 of this dissertation was to investigate 
the association between mitochondrial capacity and chronological aging. Percutaneous biopsies of 
the vastus lateralis were obtained from 68 healthy men and women with a wide range of age (20-
88yrs), body mass index (BMI, 19-47kg/m2) and cardiorespiratory fitness (VO2max: 1.08-
5.04L/min). Mitochondrial capacity was evaluated through mitochondrial respiration in 
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permeabilized myofibers and expression of proteins that mediate mitochondrial fusion, fission and 
autophagy. Mitochondrial respiration and expression of mitochondrial quality control proteins 
were elevated in young physically active individuals, but were similar among sedentary young, 
middle-aged and older subjects. The findings of this study suggest that mitochondrial capacity is 
not influenced by chronological age per se, but is closely related to BMI and cardiorespiratory 
fitness. Study 2 was performed to investigate the association between mitochondrial function and 
sarcopenia in very old adults. Specifically, the association between mitochondrial respiration and 
myofiber cross-sectional area, intramyocellular lipid content, and physical function were 
evaluated. Percutaneous biopsies from vastus lateralis were collected from 41 very old men and 
women (85-95yrs). Myofiber cross-sectional area and intramyocellular lipid content were 
evaluated histologically. Grip strength was tested by a handheld dynamometer, and knee extension 
torque was evaluated by an isokinetic dynamometer. Physical function was evaluated by physical 
performance tests including the multiple chair stand, standing balance, and gait speed. 
Mitochondrial respiration explained a significant amount of variation in grip strength and knee 
extension peak torque, and was associated with preferred gait speed. The findings of this study 
suggest that mitochondrial capacity plays a role in sarcopenia among the very old, but that other 
factors secondary to aging, including decreased physical activity and higher adiposity may 
influence this association.  
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1.0  INTRODUCTION 
1.1 STATEMENT OF THE PROBLEM 
Skeletal muscle aging is characterized by a progressive loss of muscle mass, strength, and physical 
function, known as sarcopenia (1-3). These declines are often associated with impaired mobility, 
greater tendency to fall, loss of independence, and functional limitations in the elderly population 
(4-8). Global life expectancy is increasing, and the healthcare costs with sarcopenia are also 
expected to rise. Therefore, there is a clinical, social and economic need to determine factors 
underlying reduced skeletal muscle mass and function in older subjects.  
For several decades, mitochondria have been hypothesized to play a major role in muscle 
aging (9-11). However, there is still confusion as to the precise contribution of mitochondrial 
capacity to aging muscle. Despite a great number of studies that demonstrate decreases in 
mitochondrial function with aging (11-14), several have failed to observe this association (15-18). 
These contradictory results could be partially explained by the use of different approaches and 
techniques to evaluate mitochondria. In addition to methodological factors, some studies of 
mitochondrial capacity have not controlled for other physiological factors that have been shown 
to affect mitochondria, such as adiposity and physical activity (15-18). Careful consideration of 
the methods and participant characteristics are needed when investigating age-related declines in 
mitochondrial capacity. 
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Recent data from in vitro and animal studies have strongly suggested that there may be a 
mechanistic link between mitochondria and the loss of muscle mass that occurs with aging (19-
21). In addition to changes in muscle mass, recent evidence has shown that mitochondrial capacity 
may be associated with physical function in older adults (14, 22). Human studies further 
investigating the relationship between mitochondrial capacity and muscle mass, muscle strength 
and physical performance in old subjects is needed. A better understanding of the role of 
mitochondria on skeletal muscle aging and sarcopenia will assist on the development of 
approaches to prevent and treat the decreases in muscle mass and function observed in the old 
population.  
1.2 BACKGROUND 
Sarcopenia represents a major risk factor for several negative health-related conditions. The 
development of sarcopenia is associated with a higher predisposition to injuries, loss of 
independence, functional limitations in activities of daily living, and reduced quality of life; these 
declines may ultimately lead to disability, institutionalization, and mortality (23). Several factors 
are known to influence the pathogenesis of sarcopenia, including lifestyle habits, systemic factors, 
local environment perturbations, and intramuscular specific processes (24). Among the 
intramuscular factors, mitochondrial capacity has been hypothesized to be a major contributor to 
the age-related loss of muscle mass and function (24). A thorough understanding of the 
mitochondrial processes underlying muscle aging and the pathogenesis of sarcopenia is needed.  
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1.2.1 Why study mitochondria? 
Mitochondria have been a topic of investigation for several decades. For the most part, the 
biochemistry of mitochondria has been examined in isolated systems, and its relationship with the 
rest of the cell is often not fully considered. In the past decades, the analysis of mitochondria as an 
independent and isolated organelle has changed as the development of new methodologies has 
allowed the examination of mitochondria within the cell environment (25). Additionally, the 
mitochondrion is now recognized as a dynamic organelle in which morphology is regulated 
constantly to assure proper function (26, 27). 
Mitochondrial structure is characterized by a double-membrane that separates the organelle 
into four distinct compartments (Outer membrane, intermembrane space, inner membrane and 
matrix). The inner membrane is folded into cristae, and stores the electron transport chain (ETC). 
Through ETC, mitochondria perform one of their major functions- the consumption of oxygen and 
substrates to produce adenosine triphosphate (ATP). In addition to ATP production, mitochondria 
participate in a wide range of cellular processes, including thermogenesis, regulation of the cell 
cycle, signal transduction, oxidative stress, calcium handling, heme synthesis and apoptosis. They 
are also a major source of reactive oxygen species (ROS) (28-30). 
Due to the essential role of mitochondria on cell function, it is not surprising that 
dysfunction or damage of mitochondria is hypothesized to underlie a diverse range of human 
diseases, such as neurodegenerative conditions (31), cardiac dysfunction (32), liver disease (33), 
type 2 diabetes (34), and cancer (35). Furthermore, mitochondria have been hypothesized to play 
a major role on the aging process, including the decreases in skeletal muscle mass and function 
that occurs with aging (14, 19, 20, 22, 36, 37). The wide impact of mitochondria in several diseases 
makes them an important topic for study as well as a target for therapy. 
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1.2.2 Is skeletal muscle mitochondrial capacity associated with muscle aging? 
The influence of mitochondrial capacity on age-related changes in skeletal muscle has been 
extensively investigated as a means to understand the cause of sarcopenia. The free radical theory 
of aging, which was first proposed in 1956 by Harman (9), proposes that mitochondrial free 
radicals cause oxidative damage that may ultimately lead to aging. Cells constantly generate ROS, 
and the majority of this production is generated by the mitochondria as byproducts of oxygen 
consumption in the electron transport chain (ETC) (38, 39). While ROS are fundamental for proper 
cell signaling and homeostasis, a healthy balance between ROS production and consumption is 
required (28, 40). To manage the physiological ROS production, mitochondria possess a defense 
network comprising of detoxifying enzymes and non-enzymatic antioxidants. If mitochondrial 
antioxidant defenses are working properly and electron leakage occurs within the physiological 
range, oxidative damage is almost completely prevented. However, if ROS production exceeds the 
capacity of the antioxidant defense system, oxidative damage to mitochondrial DNA may occur 
(40). Mutations in mitochondrial DNA can lead to the synthesis of defective respiratory chain 
components, which may result in impairment of oxidative phosphorylation, decreased ATP 
production and further ROS generation (39). The increased ROS production will result in further 
mitochondrial damage. This vicious cycle of oxidative stress and mitochondrial dysfunction has 
been proposed as a mechanism by which muscle aging is accelerated.  
Several studies have been conducted to investigate whether mitochondria play a role on 
skeletal muscle aging, and a significant number of them have shown decreases in mitochondrial 
function with chronological aging (11-13, 41-44). Rat and mouse studies performed in isolated 
skeletal muscle mitochondria demonstrated age-related decreases in mitochondrial content (45, 
46), ATP production (43, 44), activity of electron transport chain complexes (44), state 3 (47) and 
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state 4 (46) respiration, and mitochondrial affinity for ADP (45). Additionally, increases in 
hydrogen peroxide production (44), mitochondrial DNA oxidative damage (44), mitochondrial 
apoptotic susceptibility (48), ROS production (48) and mitochondrial swelling (47) has also been 
observed. Similarly, in vivo measurement of mitochondrial oxidative phosphorylation to 
contraction-induced increase in ATP demand has been shown to be reduced with aging in rat 
muscle (45). 
Human studies performed with muscle biopsies have confirmed the findings of animal 
studies demonstrating decreases in mitochondrial capacity with aging. Morphological changes 
include declines in mitochondrial content, expressed by reduced number, density and/or size of 
mitochondria (49-51), reduced mitochondrial DNA and mRNA (41, 52),  and decreased 
mitochondrial protein expression (41, 52, 53). Mitochondrial functional changes observed with 
aging include reduced ATP production rate (41, 52), decreased oxidative capacity (50, 53, 54), 
reduced enzymatic activity (11, 13, 49, 52-56), and lower levels of mitochondrial respiration (11-
13, 55). Additionally, in vivo human studies that utilized magnetic resonance spectroscopy have 
demonstrated reduced maximal ATP flux with aging in the gastrocnemius (57), vastus lateralis 
(50, 58) and soleus (59) muscles.  
Despite a wide number of studies describing age-related changes in mitochondrial capacity, 
several studies have failed to observe these alterations (15-17, 60, 61). Animal studies performed 
in isolated mitochondria from rat muscles have not observed age trends related to enzyme activity 
(48), state 3 respiration (46, 48), state 4 respiration (48) , and ROS production (43). Human studies 
have also reported no differences in mitochondrial capacity with aging, including mitochondrial 
content (60, 62), enzymatic activity (15), ATP synthesis (16, 60), mitochondrial respiration (16, 
17, 62), activity of electron transport chain complexes (15, 16, 60), and ROS production (55, 62). 
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Furthermore, in vivo studies have failed to demonstrate changes in maximal ATP flux with aging 
(63-66).  
It is still not clear whether there is a decrease in mitochondrial capacity with aging, 
particularly in humans. The disparity in the literature regarding the association of aging and muscle 
mitochondrial function in humans may be explained by two main factors: study methodology and 
participants’ characteristics. Study methodology such as the muscle analyzed, technique utilized 
to evaluate mitochondrial properties (ex vivo or in vivo), functional output being evaluated, and 
age-range being investigated are factors that can affect study results and need to be considered 
when comparing the outcome of different studies. Additionally, several recent studies have 
supported the influence of subject characteristics and physiological parameters, such as sex, race, 
physical fitness, body fat content/distribution, and insulin sensitivity on mitochondrial function, 
suggesting that these characteristics should also be considered when evaluating the association 
between mitochondrial capacity and aging (17, 49, 60, 67).  
1.2.3 Possible confounders of the relationship between aging and mitochondrial capacity 
While several studies have failed to demonstrate an association between age and mitochondrial 
capacity, many have suggested that declining mitochondrial capacity in older age can be attributed 
to participants’ characteristics and physiological parameters. Possible confounders of the 
relationship between aging and mitochondrial capacity include sex, race, body fat, and physical 
activity levels. 
Mitochondrial respiration of permeabilized muscle fibers was found to be higher in men 
when compared to age-matched women, suggesting that men have slightly greater quality or the 
quantity of skeletal muscle mitochondria (17). Additionally, accumulation of damaged proteins 
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and lipofuscin was shown to be more pronounced in men than in women, which means that the 
accumulation of molecular damage in skeletal muscle may differ between sexes (17). Similarly, 
high-resolution respirometry of permeabilized muscle fibers from Caucasian and African-
American women showed decreased mitochondrial respiration, content, and oxidative capacity in 
African-American women, when compared to Caucasian women (67). These findings suggest that 
sex and race may influence mitochondrial capacity and, therefore, should be considered when 
evaluating the association between aging and mitochondria. 
Body fat is another factor that has been suggested to play a role in mitochondrial function. 
While mitochondrial respiratory capacity was observed to be fully preserved with aging in a study 
performed with permeabilized human skeletal muscle, a significant negative correlation between 
mitochondrial respiration and the percentage body fat was found (17). Similarly, studies have 
shown that obese subjects present reduced capacity for lipid oxidation, and lowered activity of 
mitochondrial enzymes (68, 69).  
Lipids have an essential impact on several cellular processes, and are key mitochondrial 
fuels (70). A balance between lipid production and oxidation or storage needs to occur for a healthy 
cellular state. Increased circulating levels of lipids have shown to result in metabolic alterations in 
fatty acids utilization and intracellular signaling, process also known as lipotoxicity (71). Cells can 
protect themselves from lipotoxicity by oxidizing fatty acids or storing them as triacylglycerol 
within lipid droplets (72-74). Triacylglycerol catabolism will later release fatty acids that will be 
used for β-oxidation and ATP synthesis in the mitochondria (70). Excess free fat acids can promote 
diverse effects on the mitochondria, and can act as both uncouplers and inhibitors of mitochondrial 
respiration (75). 
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Excessive lipid droplet accumulation is a characteristic of several metabolic diseases 
including obesity. There is considerable debate in the literature whether lipid oversupply and 
mitochondrial dysfunction play a role in the development of insulin resistance, and a number of 
studies have supported this lipotoxicity hypothesis (76-80). However, it is still unclear whether 
there is a direct relationship between lipids, mitochondria dysfunction and insulin resistance, and 
if changes in mitochondrial capacity are a cause or consequence of insulin resistance. In any case, 
it is well known that lipids have a considerable impact on mitochondria. Lipids have been shown 
to affect mitochondrial function, both are associated with obesity, and body fat increases with 
aging, thus strongly supporting the inclusion of body fat as one of the covariates of this study.  
In addition to changes in body composition, aging is generally associated with decreased 
levels of physical activity. The ability of exercise to increase mitochondrial content and function 
is well documented (81, 82). Exercise training, including endurance and resistance exercise, 
stimulates mitochondrial biogenesis through increases in the peroxisome proliferator-activated 
receptor-γ coactivator-1α (PGC-1α) (83, 84). Furthermore, recent studies have suggested that 
exercise can improve function/efficiency of mitochondria through remodeling of the mitochondrial 
network (fusion, fission, and autophagy) (85-88). Additional research should be performed to 
better understand the effects of exercise training on mitochondrial quality control processes, 
especially in the aging context. In contrast with the beneficial effects of exercise, decreases in 
physical activity, such as with bed rest, have shown to result in lower mitochondrial DNA content 
and lowered activity of mitochondrial enzyme (89). These findings strongly suggest that physical 
activity influences mitochondria and therefore should also be considered when evaluating the 
relationship between aging and mitochondrial capacity.   
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Several studies have shown that mitochondrial function is not affected by chronological 
aging, but rather by decreases in physical activity that normally occurs with aging (15, 16). 
Barrientos et al. (1996) and Brierley et al. (1996) observed that the association between age and 
mitochondrial capacity disappeared after controlling for physical activity levels (15, 16). Similarly, 
no differences in mitochondrial content and respiration was observed between young and old 
subjects matched for physical activity, both engaged in moderate to vigorous-intensity exercise 
training (62).  
Studies that included a group of old trained subjects have been performed in an attempt to 
investigate whether maintenance of physical activity levels during aging can prevent decreases in 
skeletal muscle capacity. It has been shown that while old sedentary subjects present a reduced 
mitochondrial oxidative capacity when compared to young subjects, mitochondrial content, 
biogenesis, ETC function and antioxidant capacity is preserved in skeletal muscle of active older 
individuals (18). Similarly, muscle biopsies from well-trained seniors who exercised regularly in 
the previous 30 years demonstrated that lifelong physical exercise delays age-associated skeletal 
muscle declines (90). These well-trained seniors presented better mitochondria organization, 
including preserved fiber morphology and ultrastructure of intracellular organelles involved in 
Ca2+ handling and ATP production, lowered expression of genes related to autophagy and reactive 
oxygen species, in comparison with health matched sedentary senior. Likewise, age-related 
declines in oxidative capacity (54), mitochondrial ATP production (52), citrate synthase activity 
(52) have been observed in sedentary subjects, but not in endurance-trained subjects.  
Taken together, these studies suggest that mitochondrial function is influenced by subject’s 
characteristics, such as sex and race, and by physiological parameters, such as body fat and 
physical activity levels. In the present study the association between mitochondrial capacity and 
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aging was investigated. While studies have suggested the influence of sex, race, BMI, and 
cardiorespiratory fitness on mitochondrial capacity, there is still no consensus on whether 
mitochondrial capacity decreases with aging or not. None of the cited studies had performed a 
comprehensive evaluation of age-related changes in mitochondrial capacity when controlling for 
all these factors. In this dissertation study, the specific contribution of these covariates were 
evaluated using a sample of 68 muscle biopsies, from men and women with a wide range of age, 
BMI and cardiorespiratory fitness.  
1.2.4 Methods to evaluate mitochondrial capacity 
Several measurements, each with distinct advantages and limitations, are available to examine 
skeletal muscle mitochondrial capacity. The selection of the technique to be used is usually based 
on the study question and instrumentation availability. In vivo assessment of mitochondrial 
function can be achieved with the use of magnetic resonance spectroscopy (50, 64). Ex vivo 
assessment of mitochondrial capacity is possible with the collection of a skeletal muscle biopsy 
(22). Ex vivo approaches include measurement of mitochondrial content through electron 
microscopy, quantification of mitochondrial DNA, mitochondrial enzyme activity and protein 
expression of electron transport chain complexes (50, 53, 91, 92). Common measurements of 
mitochondrial function include ATP production (52, 61), mitochondrial enzyme activity (53, 93) , 
mitochondrial respiration (22) and ROS production (94). 
Magnetic resonance spectroscopy (MRS) allows an in vivo and non-invasive assessment 
of muscle oxidative capacity through measurement of ATP synthesis rate (50, 64). The ability to 
assess mitochondrial function under conditions where circulatory and regulatory systems are intact 
is the strength of this technique. However, this in vivo measurement needs to be complemented by 
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an ex vivo analysis, such as mitochondria density, to really confirm the presence of a mitochondrial 
dysfunction. 
Measurement of mitochondrial number, density and size can be achieved with the use of 
electron microscopy, which is the gold standard for analysis of mitochondrial content and 
morphology. Other analysis of mitochondrial content include measurement of cardiolipin content, 
an exclusive component of the inner mitochondrial membrane, measurement of mtDNA copy 
number, mitochondrial enzyme activities, such as citrate synthase, and expression of electron 
transport chain proteins through western blot (50, 53, 91).  
Analysis of mitochondrial enzymes, such as citrate synthase, succinate dehydrogenase and 
cytocrome c oxidase have been widely used as a measured of mitochondrial oxidative capacity 
(53). Due to requirement of small amounts of frozen tissue, the spectrophometric-based enzyme 
activity assays are a reasonable method in studying mitochondria characteristics when the 
quantities of tissue are limited. However, it is very unlikely that a single enzyme can reflect the 
collective function of mitochondria. 
Respiratory measurements of oxygen consumption of isolated mitochondria using 
polarographic oxygen electrodes has long been used to assess function of fresh isolated 
mitochondria (11). A downside of this method is that the conventional polarographic system 
requires large quantities of tissue and the sensitivity of measurement is low. A novel perspective 
of mitochondrial respiratory physiology emerges from a series of studies based on high-resolution 
respirometry (17, 95, 96). This method allow the determination of many parameters of 
mitochondrial function using small sample of biological material, which makes the analysis of 
human tissues feasible.  
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Although studies conducted with isolated mitochondria have the advantage to exclude all 
potentially confounding factors from the cellular environment, it does not preserve the complex 
structural arrangement of the organelle and it eliminates other constituents of the cell that could 
affect mitochondrial response. Additionally, the isolation procedure can cause damage to the 
mitochondria (60) and promote changes that are not representative of in vivo characteristics. A 
more recent approach utilized to examine skeletal muscle mitochondrial function is the dissection 
and permeabilization of the muscle sarcolemma yielding permeabilized myofiber bundles (17). 
This technique preserves mitochondrial structural cell interactions and morphology (25).  
A study specifically designed to compare mitochondrial respiration in aged muscles 
between isolated mitochondria and permeabilized muscle fiber bundles demonstrated that the 
mitochondrial isolation procedure exaggerated functional age-related impairments in sarcopenic 
skeletal muscle (97). Similarly, contradictory results were found with the use of isolated 
mitochondria vs permeabilized muscle fibers. The authors suggested that the discrepancy could be 
explained by a biased harvest of "healthy" mitochondria and/or disruption of structural 
components during the process of isolation (55). 
A considerable number of previous studies investigating the association between 
mitochondrial capacity and aging were performed in isolated mitochondria. In this dissertation 
study, mitochondrial function was evaluated by analysis of mitochondrial respiration in 
permeabilized muscle fibers using high-resolution respirometry. We opted for using this 
methodology to preserve the complex structural arrangement of the organelle and its interactions 
with the cell. We also assessed mitochondrial content through western blot technique, which give 
us information on the protein expression of each one of the five electron transport chain complexes.  
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1.2.5 Mitochondrial capacity may be associated with mitochondrial dynamics 
The view of mitochondria as a dynamic organelle has increased in the recent years. It is recognized 
that mitochondria structure is constantly remodeled to assure proper function. Examination of 
mitochondrial quality control processes can provide essential information regarding mitochondrial 
capacity in aging and disease, and complement standard analysis of mitochondrial morphology, 
content and function.  
Mitochondria structural and functional integrity relies on the efficiency of quality control 
processes. These processes include the mitochondrial oxidant scavenging systems, protein repair 
and degradation pathways, and mitochondrial dynamics and turnover (24, 98). ROS scavenging 
systems can prevent oxidative damage to the mtDNA, however when damage has occurred, several 
mechanisms to repair the mitochondria will be activated. Mitochondria that has suffered 
irreversible damage can be removed by the mitochondrial proteolytic system and replaced by 
newly synthetized proteins (99), while the ones that are partially damaged can be restored through 
the fusion with a neighboring intact mitochondria (98) or segregated from the vital mitochondrial 
network through fission and eventually eliminated by autophagy (98). 
Mitochondrial morphology is regulated by continuous fusion and fission, and the balance 
between them is controlled by complex mitochondrial dynamics machinery and changes in 
metabolism. Mitochondrial fusion results in the formation of a network that enables the 
mitochondria to mix their contents, redistribute metabolites, proteins, mtDNA, and prevent the 
accumulation of abnormal organelles (100). A few main proteins are involved in the fusion 
process: dynamin-related GTPases mitofusion 1 and 2 (Mfn1 and Mfn 2) are responsible for fusion 
of the outer mitochondrial membrane (101), while the optic atrophy protein 1 (OPA1) is 
responsible for fusion of the inner mitochondrial membrane (102). The other quality control 
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process used by the mitochondria is fission. This process segregates components of the 
mitochondria that are irreversibly damaged or unnecessary, allowing for their autophagic removal 
(103). Mitochondrial fission is regulated by the dynamin-related protein 1 (Drp1) (104) and fission 
protein 1 (Fis 1) (105). A functional link exists between mitochondrial dynamics and autophagy. 
The segregation of damaged mitochondria by fission and inhibition of their fusion are prerequisites 
for their autophagic degradation (98).    
Autophagy is a “self-eating” process through which cells degrade their own components 
(damaged or unnecessary cellular proteins and organelles) allowing for the recycling and reuse of 
the structures (106). Briefly, autophagy occurs through the sequestration of damaged organelles 
into a double-membrane structure known as autophagosome (106). Autophagosomes then fuse 
with lysosomes to form autolysosomes, in which the enveloped content is degraded. Autophagy 
can be specifically directed towards the degradation of mitochondria, known as mitophagy. 
Mitophagy is responsible for regulating the total number of mitochondria to match metabolic 
demands and serves as a quality control mechanism to remove damaged organelles (107). 
While the orchestration of fusion and fission are important for maintaining mitochondrial 
integrity, few animal and human studies have examined mitochondrial quality control process in 
muscle aging, and the results are contradictory. Lower levels of mitochondrial fusion protein 
Mfn2, and increased expression of fission protein FIS1 and DRP1 were reported in skeletal muscle 
of aged rats when compared to young controls (108). A recent human study performed with young 
and old subjects observed no age-related changes in fusion and fission proteins (109). Conversely, 
a decreased expression of the fusion marker OPA-1 has been reported in low-functioning elderly 
subjects when compared to young and high-functioning elderly individuals (14), while no changes 
in fission were observed. Decreased Mfn2 gene expression was also observed in old individuals 
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when compared to young individuals (49). Similarly, studies investigating changes in autophagy 
are also contradictory and have shown both increases and decreases with aging (20, 110-112). 
In this study, we proposed to explore the association between expression of fusion, fission 
and autophagy proteins with aging, using a group of young, middle-aged and old subjects. We 
hypothesized a decrease in both mitochondrial fusion (reduced expression of OPA1 and Mfn2 
proteins) and fission (reduced expression of Fis1 and DRP1 proteins) in the old group when 
compared to young and middle-aged groups, figure 1. Additionally, we hypothesize that with 
reduced fission damaged components of dysfunctional mitochondria are not segregated for 
subsequent elimination by autophagy (reduced expression of Beclin1, LC3 and BNIP3), figure 1. 
While we believe that mitochondrial fusion, fission and autophagy are decreased with aging, we 
hypothesize that these changes are associated with age-related changes in BMI and 
cardiorespiratory fitness.  
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Figure 1. Hypothesis schematic for age-related decreases in mitochondrial capacity.  
* Blue headings indicate mitochondrial measures of study 1; Red arrows indicate direction of changes hypothesized 
to occur with aging. 
1.2.6 Potential links between mitochondrial capacity and sarcopenia 
Given the central role of mitochondria in cellular quality control and cell death pathways, it is not 
surprising that impaired mitochondrial function is hypothesized to play a major role in the age-
related loss of muscle mass and function. Changes in mitochondrial respiratory capacity, 
imbalance between mitochondrial fusion and fission, and failure of mitochondrial turnover 
resulting from insufficient biogenesis and/or defective autophagic removal of dysfunctional 
mitochondria are all factors that may be involved in the loss of muscle mass during aging. 
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Specifically, it is hypothesized that mitochondrial dysfunction and increased ROS production 
stimulates catabolic signaling pathways, and muscle atrophy by activating the two major 
proteolytic systems: the ubiquitin proteasome and the autophagy lysosome (113, 114).  
Several in vitro and animal studies have provided information on the molecular pathways 
involved in these processes (19, 21, 113, 115). Forkhead Box O (FoxO) transcription factors have 
been identified as the main coordinators of the two proteolytic pathways by stimulating several 
autophagy-related genes (such as LC3 and BNIP3) as well as ubiquitin ligases (atrogin-1 and 
MuRF-1). Excessive activation of autophagy had been shown to aggravate muscle wasting by 
removing a portion of cytoplasm, proteins, and organelles (115). In contrast, inhibition of 
autophagy has been shown to result in muscle degeneration and weakness (19). The exact role of 
these processes in regulating muscle mass still remains poorly understood in humans. 
Despite several lines of evidence indicate an association between mitochondrial capacity 
and sarcopenia, limited human studies directly investigated the relationship between mitochondrial 
capacity with muscle function and physical performance in very old adults. Recent evidence has 
shown that lower mitochondrial capacity and efficiency is associated with reduced physical 
performance in older adults (22). Similarly, high-functioning elderly individuals have been shown 
to maintain muscle mass and mitochondrial capacity, while low-functioning elderly individuals 
demonstrate decreased muscle mass and mitochondrial function in comparison to young 
individuals (14). These results suggest an association of mitochondria with physical function. In 
the present study, the association between mitochondrial respiratory capacity and myofiber cross-
sectional area as a measure of muscle size, intramyocellular lipid content, and physical function 
was investigated. The findings of this study complement the previous findings by using a group of 
very old individuals (85-95yrs), in which decreases in muscle mass and physical function are 
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pronounced and the associations more likely to be established, by investigating the association 
between mitochondrial capacity and muscle size at the cellular level, and by comprehensively 
investigating the association between mitochondrial capacity and physical function. 
1.3 SIGNIFICANCE 
According to the U.S. Census Bureau, the elderly population will more than double by 2040 when 
compared to 2000 (116, 117). The current challenge for researchers and clinicians is how to expand 
active life expectancy, free of disability. The development of sarcopenia is commonly associated 
with reduced quality of life, and may ultimately lead to disability, institutionalization and 
mortality. Despite the clinical and social relevance of sarcopenia, the exact biochemical and 
molecular mechanisms involved in this process are not completely understood, especially in 
humans. In this ancillary study we proposed not only to investigate biochemical factors that may 
play a role in human sarcopenia, but also to investigate how these biological characteristics 
translate to muscle function and physical performance. This translational research initiative is an 
essential step to establish the possible role of mitochondria on age-related decreases in muscle 
mass and function, and it is the basis for the development of preventive approaches and effective 
rehabilitation for sarcopenia.  
In Study 1 of this dissertation we investigated the association between mitochondrial 
capacity and chronological aging. While this has been a topic of investigation of several other 
studies, there is still confusion as to the precise contribution of mitochondrial capacity to aging 
muscle. Study 1 was conducted to elucidate issues still debated in the literature. First, 
measurements of mitochondrial function were investigated in permeabilized muscle fibers using 
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high-resolution respirometry, the gold standard method for the analysis of mitochondrial 
respiration. Second, we explored the specific contribution of potential confounders such as sex, 
race, BMI and cardiorespiratory fitness on the association between mitochondrial capacity and 
aging. Third, few human studies have investigated changes in mitochondrial dynamics with aging. 
In addition to investigate the association between proteins that mediate mitochondrial dynamics 
with aging, this study investigated the influence of BMI and cardiorespiratory fitness on 
mitochondrial quality control proteins.  
In Study 2 of this dissertation, we investigated the association between mitochondrial 
capacity and sarcopenia. Despite in vitro and animal studies strongly suggest that mitochondria 
play a major role in the loss of muscle mass (19-21), human studies designed to investigate whether 
mitochondrial capacity associates with muscle mass, muscle fat, muscle strength and physical 
performance in very old subjects are lacking. A cohort of very old subjects (85-95yrs) was selected 
to participate in this study because at this age decreases in muscle mass and physical function are 
pronounced and associations with mitochondria more likely to be established.  
The results of this dissertation study provide a better understanding of: 1. the association 
between mitochondrial capacity and aging; 2. the influence of adiposity and cardiorespiratory 
fitness on the association between mitochondrial capacity and aging; 3. the influence of 
mitochondrial fusion, fission and autophagy on muscle aging; and 3. the association of 
mitochondrial capacity with muscle size and physical function in an old population.  
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1.4 INNOVATION 
The relationship between mitochondrial capacity and aging and sarcopenia was investigated in 108 
skeletal muscle biopsies, including a group of very old (85-95yrs) subjects. Subjects participating 
in this study present a wide range of age, BMI, and cardiorespiratory fitness, which gives us the 
unique opportunity to investigate the association between mitochondria and aging, when 
controlled for body fat and physical fitness. While other ex vivo studies have examined the 
relationship between mitochondrial capacity and age, this is the first time, to our knowledge, that 
muscle biopsies are collected from a cohort of 41 very old individuals (85yrs and older).  
This study utilized innovative techniques to investigate mitochondrial respiration. Several 
studies have demonstrated significant age-related alterations in mitochondrial capacity (11, 41, 49, 
52). The majority of these studies were performed in isolated muscle mitochondria, a widely 
employed method when examining mitochondrial function in aging. However, this method does 
not preserve the complex structural arrangement of mitochondria, and there is a possibility that the 
isolation procedure exposes vulnerabilities in aged mitochondria that are not evident in vivo (97). 
A more recent approach utilized to examine skeletal muscle mitochondrial function is the 
dissection and permeabilization of the muscle sarcolemma yielding permeabilized myofiber 
bundles. This technique preserves mitochondrial interactions and morphology (25). A study 
specifically designed to compare mitochondrial respiration in aged muscles between isolated 
mitochondria and permeabilized muscle fiber bundles demonstrated that the mitochondrial 
isolation procedure exaggerated functional age-related impairments in sarcopenic skeletal muscle 
(97). In the present study, saponin-permeabilized fiber bundles were used to assess mitochondrial 
respiratory capacity. 
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Using human samples, we examined novel biochemical markers of mitochondrial capacity. 
Moreover, this study used comprehensive methods to give a broad understanding of mitochondrial 
capacity on the aging process. The importance of efficiency of mitochondrial quality control 
process for proper muscle capacity has been extensively highlighted in the recent years (24, 118). 
Using human samples, this study examined associations between quality control proteins, i.e. 
proteins responsible for mitochondrial fusion, fission and autophagy, and muscle aging. 
Additionally, this study explored the influence of BMI and cardiorespiratory fitness on these 
processes.  
We investigated whether mitochondrial capacity associates with myofiber area and lipid 
content, muscle strength and physical performance in very old individuals. It is well established 
that aging is characterized by pronounced muscle atrophy and declines in functional capacity (1, 
2). However, muscle mass and strength do not decline in the same proportion (119, 120), 
suggesting that the decrease in muscle mass does not alone explain decreases in muscle strength 
and physical function. Other physiological factors, such as neurological, vascular, and hormonal 
changes may also contribute to these declines (121). In this study, we aimed to investigate the 
contribution of mitochondrial capacity to declines in muscle strength and physical performance.  
1.5 AIMS AND HYPOTHESIS 
The overall purpose of this dissertation study was to determine the association of mitochondrial 
capacity with chronological age and sarcopenia. We hypothesized that mitochondrial capacity is 
associated with age, but this association is attenuated when controlled for body mass index and 
cardiorespiratory fitness. Furthermore, we hypothesized that lower mitochondrial capacity is 
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associated with increased intramyocellular lipid content, and decreased myofiber cross-sectional 
area, muscle strength and physical performance. 
1.5.1 Specific aims and hypotheses of study 1 
Determine the association between chronological age and mitochondrial capacity (respiration, 
content, and expression of quality control proteins) using a group of young (20-30yrs), middle-
aged (31-60yrs) and older (61 and older) subjects, and to examine if there is an association between 
age and mitochondrial capacity after controlling for body mass index and cardiorespiratory fitness. 
Hypothesis 1a: Mitochondrial respiration and content will be lower in the middle-aged and 
old groups when compared to young, and lower in the old group when compared to middle-aged 
group.  
Hypothesis 1b: Mitochondrial fusion, fission and autophagy will be reduced in the middle-
aged and old groups when compared to young, and reduced in the old group when compared to 
middle-aged group. 
Hypothesis 1c: When controlled for body mass index and cardiorespiratory fitness the 
association between mitochondrial capacity and chronological age will be attenuated.  
1.5.2 Specific aim and hypothesis of study 2 
Determine the association between mitochondrial respiratory capacity and myofiber cross-
sectional area, intramyocellular lipid content, and physical function in a group of very old subjects 
(85yrs and older). 
23 
Hypothesis: Mitochondrial respiratory capacity will be negatively associated with 
intramyocellular lipid content, and positively associated with myofiber cross-sectional area and 
physical function. 
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2.0  CARDIORESPIRATORY FITNESS AND ADIPOSITY, BUT NOT 
CHRONOLOGICAL AGE, INFLUENCE SKELETAL MUSCLE MITOCHONDRIAL 
RESPIRATION AND QUALITY CONTROL PROTEINS IN YOUNG, MIDDLE-AGED 
AND OLDER ADULTS  
2.1 SUMMARY 
Considerable debate continues to surround the concept of mitochondrial dysfunction in aging 
muscle. We tested the overall hypothesis that cardiorespiratory fitness (VO2max) and adiposity 
(BMI) more strongly correlate with mitochondrial function and markers of mitochondria quality 
control, i.e., expression of fusion, fission and autophagy proteins, than age per se. Methods: 
Percutaneous biopsies of the vastus lateralis were obtained from sedentary young (n=14, 24±3yrs), 
middle-aged (n=24, 41±9yrs) and older adults (n=20, 78±5yrs). A physically active group of young 
adults (n=10, 27±5yrs) was studied as a control. Mitochondrial respiration was determined in 
saponin permeabilized fiber bundles. Fusion, fission and autophagy protein expression was 
determined by western blot. Cardiorespiratory fitness was determined by a graded exercise test. 
Results: Mitochondrial respiratory capacity and expression of fusion (OPA1 and MFN2) and 
fission (FIS1) proteins were not different among sedentary groups despite a wide age range (21 to 
88yrs). Mitochondrial respiratory capacity and fusion and fission proteins were, however, 
negatively associated with BMI, and mitochondrial respiratory capacity was positively associated 
with cardiorespiratory fitness. The young active group had higher respiration, complex I and II 
respiratory control ratios, and expression of fusion and fission proteins. Finally, the expression of 
fusion, fission, and autophagy proteins were linked with mitochondrial respiration. Conclusions: 
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Mitochondrial respiration and markers of mitochondrial dynamics (fusion and fission) are not 
associated with chronological age per se, but rather are more strongly associated with BMI and 
cardiorespiratory fitness. 
2.2 INTRODUCTION 
Age-associated decline in skeletal muscle mitochondrial capacity has been extensively studied as 
an underlying factor for sarcopenia (14, 62), a condition characterized by a progressive loss of 
muscle mass and strength (2), and slower walking speed (22) and fatigability (122). However, 
while numerous cross-sectional human studies have demonstrated decreases in mitochondrial 
capacity with chronological age (11, 13, 41, 52, 55, 123), several others have failed to observe 
these changes (17, 61, 62, 124, 125). The inconsistent results may be partially due to the various 
definitions of the term “mitochondrial function” and the different approaches employed to assess 
mitochondrial function, including: respiration (22), ATP production (52, 61), mitochondrial 
permeability transition pore function, (62) and H2O2 emission (94). Furthermore, several of these 
investigations were performed in isolated mitochondria (11, 13, 41), which has been shown to 
exaggerate the observed deficit in mitochondrial function, when compared to measurements 
conducted on permeabilized myofibers (97). Moreover, most studies of mitochondrial respiration 
have not controlled for important covariates such as participant physical activity levels (13), 
adiposity (41), which could confound the relationship between mitochondrial capacity and age 
(17, 18, 52, 54). Collectively, these studies suggest that careful consideration of the methods and 
participant characteristics are needed when investigating age-related declines in mitochondrial 
function.  
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The mitochondrial reticulum is dynamic and undergoes constant remodeling through 
fusion, fission (126) and recycling by autophagy (127). Emerging evidence indicates that these 
processes are essential for the maintenance of a healthy mitochondrial pool (118). Mitochondrial 
fusion is regulated by proteins mitofusion-1 and -2 (MFN1 and MFN2) and optic atrophy-1 
(OPA1). Fusion allows the components of the mitochondria to be exchanged and diluted, which is 
thought to prevent mutations in mitochondrial DNA caused by respiratory dysfunction (128). 
Mitochondrial fission is regulated by proteins fission-1 (FIS1) and dynamin-related protein 1 
(DRP1). Fission segregates damaged portions of the mitochondria for removal by mitophagy 
(mitochondrial specific autophagy) (129). While the orchestration of fusion, fission, and 
autophagy are important for maintaining mitochondrial integrity, few human studies have 
examined mitochondrial quality control in aging and how they relate to other mitochondrial 
functions (14, 109).   
The purpose of this study was to comprehensively assess mitochondrial respiratory 
characteristics across a wide age range using permeabilized myofibers, while controlling for 
participant cardiorespiratory fitness (VO2max), and body mass index (BMI). We also sought to 
determine whether the expression of mitochondrial quality control proteins is affected by age. We 
hypothesized that mitochondrial respiration and expression of quality control proteins would be 
unaffected by chronological age per se, but would be more closely associated with age-related 
changes in BMI and cardiorespiratory fitness.  
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2.3 METHOD 
2.3.1 Study design 
This cross-sectional ancillary study utilized data from three cross-sectional research studies 
conducted at the University of Pittsburgh’s Endocrinology and Metabolism Research Center. The 
first study was designed to investigate mechanisms associated with lipid-induced insulin 
resistence. Subjects were recruited through print advertisements in the Pittsburgh (PA) area, and 
were medically screened at the University of Pittsburgh's Clinical and Translational Research 
Center (CTRC). A total of 30 men and women (30-35yrs), consisting of 13 sedentary lean, 14 
sedentary obese, and 14 young active participated in the parent study. Subjects in the young active 
group performed less than 1 structured physical activity session per week, while the young active 
group engaged in 3-5 structured physical activity sessions per week as determined by self-report. 
The active young control group predominantly engaged in endurance cycling and running. The 
second study was undertaken in middle-aged subjects to examine markers of nutritional stress in 
obesity and type 2 diabetes mellitus (T2DM). Subjects were recruited through print advertisements 
in the Pittsburgh (PA) area, and were medically screened at the University of Pittsburgh's CTRC. 
A total of 26 sedentary men and women (30-55yrs), consisting of 10 lean, 9 obese non-diabetic, 
and 7 obese with T2DM were included in the study. Only the subjects without T2DM participated 
in this ancillary study. The third study was conducted to examine the relationships between muscle 
function and physical performance with measurements of mitochondrial function in a cohort of 
older adults. A total of 21 men and 16 women with BMI between 21-31kg/m2 were recruited. 
Subjects were included in the study if they were able to walk without the assistance of a device or 
another person; were free of basic activities of daily living (ADL) disability (defined as no 
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difficulty getting in and out of bed or chairs, and no difficulty walking across a small room). 
Specific exclusion criteria for old subjects include history of hip fracture, heart attack, angioplasty, 
or heart surgery within the past 3 months; cerebral hemorrhage within the past 6 months; stroke 
within the past 12 months; chest pain during walking in the past 30 days; symptomatic 
cardiovascular or pulmonary disease; regular pain, aching, or stiffness in the legs, hips, knees, feet, 
or ankles when walking; bilateral difficulty bending or straightening fully the knees; regularly 
taking Coumadin, Plavix, Aggrenox, Ticlid, or Agrylin/Xagrid. 
2.3.2 Subjects 
Sixty-eight men and women were included in this ancillary study. Subjects were eligible if they 
were between the ages of 20-90 years, were weight stable (+/-3kg in preceding 3 months), and in 
good general health. Subjects were excluded if they were participating in another interventional 
research study, had a chronic medical condition (such as heart disease, renal insufficiency, liver 
disease/cirrhosis, cancer, or any disease that requires anticoagulants and steroids), and were 
pregnant or breast-feeding. All subjects provided written informed consent and the study was 
approved by the University of Pittsburgh Institutional Review Board. 
2.3.3 Groups 
Subjects were recruited into one of the following groups: young sedentary (YS, 21-30yrs), middle-
aged sedentary (MAS, 31-55yrs), older sedentary (OS, 70-88yrs), and a young active control group 
(YA, 21-33yrs) based on age and physical activity levels. The sedentary subjects performed ≤1 
structured physical activity session per week of <20min, while the young active group engaged in 
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3-5 structured physical activity sessions per week as determined by self-report. The active young 
control group predominantly engaged in endurance cycling and running. 
2.3.4 Clinical measures 
Participants attended an assessment visit where they provided general demographics including 
date of birth, gender, and race. Additionally, data on subjects’ body weight and height were 
collected and body mass index (BMI) of each participant were calculated (individual's body mass 
divided by the square of their height, kg/m2) and used as an indication of body fat and obesity. 
Cardiorespiratory fitness (VO2max) was determined as peak aerobic capacity measured using a 
graded exercise protocol, as previously described (22, 130). Briefly, subjects breathed through a 
mouthpiece connected to a two way breathing valve (Hans Rudolph, Kansas City, MO) during the 
test, and expired air was collected via open-circuit spirometry (AEI Technologies, Pittsburgh, PA) 
to determine oxygen consumption (VO2) and carbon dioxide production (VCO2). Heart rate, blood 
pressure, and ECG were recorded before, during, and immediately after the test. The test was 
terminated as per the criteria outlined in the American College of Sports Medicine exercise testing 
guidelines (131). 
2.3.5 Skeletal muscle biopsy procedure 
Percutaneous muscle biopsies were obtained at the University of Pittsburgh’s Clinical 
Translational Research Center on a morning after an overnight fast. Participants were instructed 
not to perform physical exercise 48 hours prior to the biopsy procedure. Biopsy samples were 
obtained from the middle region of the vastus lateralis under local anesthesia (2% buffered 
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lidocaine) as described previously (132). A portion of the biopsy specimen (~10mg) was placed in 
ice-cold preservation buffer (BIOPS) (22) for analysis of mitochondrial respiration. The remaining 
muscle tissue were processed for histochemistry (~30 mg) or frozen in liquid nitrogen (~50mg) 
and stored at −80°C.  
2.3.6 Mitochondrial respiratory capacity 
Immediately after the biopsy procedure, permeabilized myofiber bundles were prepared as 
previously described (22). Briefly, myofiber bundles were gently teased apart in a petri dish 
containing ice-cold BIOPS solution using 2 sharp tweezers and a dissecting microscope (Leica 
Microsystems, Heerbrugg, Switzerland). The myofiber bundles were then permeabilized with 
saponin (2 mL of 50 ug/mL saponin in BIOPS solution) for 20 minutes at 4°C on an orbital shaker, 
and then washed twice for 10 minutes at 4°C with MIR05 respiration medium (22).  
Mitochondrial respiratory capacity in permeabilized myofibers was evaluated by high-
resolution respirometry (Oxygraph-2k, Oroboros Instruments, Innsbruck, Austria) through the 
sequential addition of substrates, inhibitor and uncoupler (figure 2). Measurements were 
performed in duplicate, at 37°C, in the range of 230-150 nmol O2/ml. LEAK (LI) respiration was 
determined through the addition of pyruvate (5mM), malate (2mM) and glutamate (10mM). ADP 
(5mM) was added to elicit complex I supported oxidative phosphorylation (OXPHOS) (PI). 
Cytochrome c (10μM) was added to check the quality of the muscle fiber preparation and assess 
the integrity of the outer mitochondrial membrane. Any sample that showed an increase in 
respiration of more than 15% with the addition of cytochrome c was not included in the final 
analysis. Succinate (10mM) was then added to elicit complex I+II supported OXPHOS (PI+II). 
FCCP (1uM) was added to determine electron transfer system (ETS) capacity or maximal 
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uncoupled respiration. Finally, rotenone (1µM) was added to inhibit complex I supported 
OXPHOS respiration, and the remaining respiration revealed the maximal ETS capacity with 
complex II substrates only (EII). Following the assay, myofiber bundles were recovered, dried, and 
weighted on an analytical balance (Mettler Toledo, XS105). Steady state O2 flux for each 
respiratory state was determined and normalized to myofiber bundle dry weight using Datlab 4 
software (Oroboros Instruments, Innsbruck, Austria). 
Respiratory control ratios/factors were calculated to investigate intrinsic mitochondrial 
respiratory capacity. Since the different respiratory states were evaluated in the same myofiber 
bundle, and therefore same population of mitochondria, this approach is a valuable method to 
estimate mitochondrial function/quality independent of mitochondrial content, quality of myofiber 
bundle preparation, and unintentional variation in assay conditions (123). Respiratory acceptor 
control ratios were calculated as PI/LI and PI+II/LI. Considering maximal uncoupled respiration 
(EI+II) as an internal measure of the ETS capacity, flux control ratios were calculated for leak 
respiration (LI/EI+II), complex I supported OXPHOS respiration (PI/EI+II), and complex I+II 
supported OXPHOS respiration (PI+II/EI+II). The results from the flux control ratios offer an 
estimation of the leak and OXPHOS capacity within the ETS capacity. Complex I (CI) and 
complex II (CII) control factors were calculated to investigate the relative change of O2 flux in 
response to a transition of substrate availability in a defined coupling state. CI control factor 
corresponds to the difference between complex I+II supported OXPHOS respiration and EII 
respiration. CII control factor corresponds to the difference between complex I+II supported 
OXPHOS respiration and complex I only supported OXPHOS respiration.  
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Figure 2. Representative oxygraph generated from the titration protocol. 
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2.3.7 Myofiber distribution and cross-sectional area 
Histochemical analyses were performed on serial sections using methods previously described 
(22). Briefly, biopsy samples were sectioned (10 m) on a cryostat (Cryotome E; Thermo Shandon, 
Pittsburgh, PA) at -20 °C and placed on individual pre-cleaned glass slides (Fisherfinest, Fischer 
Scientific, Pittsburgh, PA). Sections were incubated with primary antibodies for anti-human 
myosin heavy chain (MYH)-7 (type I myocytes), and MYH-2 (type IIa myocytes) (Santa Cruz 
Biotechnologies, Santa Cruz, CA) overnight at room temperature. Samples were then incubated 
with rhodamine (type I myocytes) and fluorescein (FITC) (type IIa myocytes) conjugated 
secondary antibodies (Santa Cruz Biotechnologies, Santa Cruz, CA). Type IIx fibers remained 
unstained. Images were visualized using a Leica microscope (Leica DM 4000B; Leica 
Microsystems, Bannockburn, IL), digitally captured (Retiga 2000R camera; Q Imaging, Surrey, 
Canada), and analyzed using specialized software (Northern Eclipse, v6.0; Empix Imaging, 
Cheektowaga, NY).  
2.3.8 Mitochondrial content and quality control proteins 
Muscle homogenates were prepared as previously described (133). Proteins were separated by gel 
electrophoresis using a 4-20% gel (Bio-Rad, Mini-PROTEAN® TGX™ Precast Gel) and 
transferred onto polyvinylidene difluoride membranes (Bio-Rad Laboratories, Hercules, CA). 
Membranes were blocked in 5% non-fat milk, and incubated with the following primary antibodies 
overnight: DRP1 and OPA1 (BD Biosciences, San Jose, CA, 1:500), Fis1 (Enzo Life Sciences, 
Farmingdale, NY, 1:1000), Mfn2 and BNIP3 (Sigma Aldrich, St. Louis, MO, 1:500, 1:1000), 
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beclin-1 and LC3A/B (Cell Signaling, Danvers, MA, 1:1000), OXPHOS (MitoSciences, Eugene, 
OR, 1:1000) and anti-α tubulin (Santa Cruz Biotechnology, Santa Cruz, CA, 1:1000). Membranes 
were then incubated in appropriate species-specific HRP-conjugated secondary antibodies (Cell 
Signaling, Danvers, MA). Protein bands were visualized using a chemiluminescence detection kit 
(Bio-Rad Laboratories, Hercules, CA) and gel documentation system (ChemiDoc XRS+; Bio-Rad, 
Hercules, CA). Protein bands were quantified by densitometry using the software ImageJ (National 
Institutes of Health, Bethesda, MD). Protein loading was controlled by normalizing bands of 
interest to -Tubulin expression. Gel-to-gel variation was controlled for by using a standardized 
sample on each gel.  
2.3.9 Power calculation 
Hypotheses 1a and 1b: The primary outcome of this study was complex I+II supported OXPHOS 
respiration (PI+II) and was the basis for power calculation. A previous study performed in our 
laboratory found that a group of old subjects present a mean ± SD value of 174 ± 68pmol/s*mg 
dry weight for this variable (22). Using these published values for PI+II respiration, an alpha level 
of 0.05, 2-tailed test, and at least 20 subjects per age group, this study has 81% power to detect 
difference in PI+II respiration between groups as small as 25%. Power calculation was performed 
using G*Power 3.1 software. 
Hypothesis 1c: To test hypothesis 1c at an alpha level of 0.05, with a total sample size of 
68 subjects, this study has 82% power to detect an R-square of 15% attributed to 4 independent 
variables (Sex, race, BMI and cardiorespiratory fitness) and aging accounting for an additional 
10% of the variability. Power calculation was performed using SPSS SamplePower 3.0 software. 
35 
2.3.10 Statistical analysis 
In order to test group differences Shapiro-Wilk and Levene’s tests were initially performed to 
assess normality of data and equality of variances, respectively. If assumptions of normality and 
homogeneity of variances were met, a One-way ANOVA followed by post-hoc Tukey tests were 
performed to compare differences across groups. If assumptions were not met, comparisons 
between groups were performed using the non-parametric Kruskal-Wallis test, followed by Mann-
Whitney U tests. The distribution of sex and race across groups were determined by Chi-squared 
test. Multiple linear regressions were performed to test whether BMI and cardiorespiratory fitness 
play a role on the association between mitochondrial capacity and age. Sex and race were also 
tested as potential covariates. Bivariate correlations were first tested to investigate relationships 
between mitochondrial variables and age, with the covariates. Each of the covariates were 
controlled in the regression model if they significantly associated with the dependent and 
independent variable. Assumptions for the use of multiple linear regression were checked. 
Analyses were performed using IBM SPSS v22.0 software (Armonk, NY). Statistical significance 
was established at p≤0.05. 
2.4 RESULTS 
2.4.1 Participant characteristics 
The participant characteristics can be found in Table 1. A total of 68 individuals with a wide range 
of age (20-88yrs), BMI (19-47kg/m2) and VO2max (1.08-5.04L/min) participated in this study. 
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There were no baseline differences in sex and race among groups (p>0.05) tested by the chi-
squared test. However, the ratio for gender and race were different between the groups. The YS 
and MAS groups had a higher weight and BMI than the YA and OS groups (p<0.05). 
Cardiorespiratory fitness was the highest in the YA group and lowest in the OS group (p<0.05). 
 
Table 1. Subject characteristics of study 1 
 Young 
Active 
(YA) 
Young 
Sedentary 
(YS) 
Middle-aged 
Sedentary 
(MAS) 
Older 
Sedentary 
(OS) 
N 10 14 24 20 
Sex (ratio) 4M/6F 5M/9F 6M/18F 12M/8F 
Race (ratio) 10C 9C/3AA/2O 15C/6AA/1A/2O 19C/1AA 
Age (years) 27±5 24±3 41±9** 78±5 *** 
Weight (kg) 62.3±7.4 85.1±28.5* 86.7±22.2* 70.6±12.4 
BMI (kg/m2) 21.4±1.2 29.2±8.0* 30.8±7.5* 25.9±3.0**** 
VO2max (L/min) 3.50±0.93 2.59±0.79* 2.27±0.81* 1.47±0.45*** 
Values are Mean±SD, n=10-24 in each group.* P<0.05 vs. YA, ** P<0.05 vs. YA and YS, *** 
P<0.05 vs. YA, YS and MAS, **** P<0.05 vs. MAS. Abbreviations: M (male), F (female), C 
(caucasian), AA (african american), A (asian), O (other), and BMI (body mass index). 
 
2.4.2 Myofiber type and cross-sectional area 
The YA group had a higher percentage of type I fibers, and a lower percentage of type II fibers, 
compared to the YS, MAS and OS groups (p<0.05, Table 2). Additionally, the YA and OS groups 
presented a lower percentage of type IIx fibers compared to the YS and MAS groups (p<0.05, 
Table 2). There were no significant differences in cross-sectional area for any fiber type among 
groups (p>0.05).  
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Table 2. Myofiber type distribution and cross-sectional area 
 Young 
Active 
(YA) 
Young 
Sedentary  
(YS) 
Middle-aged 
Sedentary 
(MAS) 
Older 
Sedentary  
(OS) 
 Fiber Type (%)     
Type I 60±9 46±10* 41±11* 47±16* 
Type II 40±9 54±10* 59±11* 53±16* 
       Type IIa 37±10 37±8 41±8 47±14 
       Type IIx 4±3 17±10** 18±8** 7±7 
Cross-Sectional Area (µm2)     
Type I 4122±1110 4046±1202 4379±1304 3934±1291 
Type II 3716±913 4092±1060 4248±1333 3141±1492 
       Type IIa 3586±785 3773±917 3990±1337 3201±1302 
       Type IIx 4023±1288 4484±1534 4506±1557 2931±1894 
Values are Mean±SD, n=5-18 in each group. * P<0.05 vs. YA, ** P<0.05 vs. YA and OS. 
2.4.3 Mitochondrial respiration 
When examining only the sedentary groups, there were no age-related deficits in mitochondrial 
respiration (Figure 3A, p>0.05). The sedentary groups presented lower LI, PI, PI+II, EI+II, and EII 
respiration compared to the YA group (Figure 3A; p<0.05). Respiratory acceptor control ratios 
were not different among the groups (p>0.05; PI/LI: 5.3±2.4, PI+II/LI: 9.7±4.3). While LI/EI+II and 
PI/EI+II flux control ratios did not differ across groups, we found that the OS group had higher 
PI+II/EI+II flux control ratio when compared to MAS group (Figure 3B; p<0.05). CI and CII control 
factors were both reduced in the sedentary groups compared to the YA group (Figure 3C; p<0.05).  
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Figure 3. Mitochondrial respiratory capacity in young, middle-aged and older individuals. 
(A) Mitochondrial respiration consisting of complex I supported Leak (LI) respiration, complex I 
supported OXPHOS (PI) respiration, complex I+II supported OXPHOS (PI+II) respiration, 
maximal electron transfer system (ETS) capacity with substrates for complex I and II (EI+II), and 
ETS with substrates for complex II (EII). (B) Respiratory flux control ratios were determined as an 
estimation of leak and OXPHOS capacity within the ETS capacity. (C) Complex I (CI) control 
factor measured as PI+II minus EII respiration, and Complex II (CII) control factor measured as PI+II 
minus PI. Data presented as Mean and SD; n=9-20 per group. *p<0.05 vs. YA, **p<0.05 vs. OS. 
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While we observed that mitochondrial respiration was not influenced by sex (Figure 4), 
race (Figure 5) or fiber type percentage (Table 3) (p>0.05), we found that it was negatively 
associated with BMI and positively associated with cardiorespiratory fitness (VO2max) (Table 4 
and Figure 6; p<0.05). We then examined the association between mitochondrial respiration and 
age when controlled for these covariates (BMI and VO2max) (Table 6). We found that BMI and 
VO2max combined to explain 31-45% of the variance of mitochondrial respiration (p<0.05), 
depending on the respiratory state, with age explaining only an additional 1.4-6.8% of the variance 
in mitochondrial respiration (Table 6; p<0.05 for LI and EI+II, and p>0.05 for PI and PI+II). The YA 
subjects are likely driving these associations since they had higher VO2max values and lower BMI 
when compared to the other groups (Table 1). We next examined the association between 
mitochondrial respiration and age when controlled for BMI and VO2max in the sedentary subjects 
only. While BMI and VO2max combined explained between 12-27% of the variance in 
mitochondrial respiration (p<0.05), we found that when these covariates are controlled for, age 
does not explain a significant percent of variance in mitochondrial respiration (Table 6, p>0.05). 
Collectively, these findings suggest that BMI and cardiorespiratory fitness, rather than 
chronological age per se, are more influential to mitochondrial respiratory capacity. 
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Figure 4. Mitochondrial respiratory capacity in males and females. 
(A) Mitochondrial respiration consisting of complex I supported Leak (LI) respiration, complex I 
supported OXPHOS (PI) respiration, complex I+II supported OXPHOS (PI+II) respiration, 
maximal electron transfer system (ETS) capacity with substrates for complex I and II (EI+II), and 
ETS with substrates for complex II (EII). (B) Respiratory flux control ratios were determined as an 
estimation of leak and OXPHOS capacity within the ETS capacity. (C) Complex I (CI) control 
factor measured as PI+II minus EII respiration, and Complex II (CII) control factor measured as PI+II 
minus PI. Data presented as Mean and SD; n=25 for male and n=34 for female. 
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Figure 5. Mitochondrial respiratory capacity in Caucasians and African Americans. 
(A) Mitochondrial respiration consisting of complex I supported Leak (LI) respiration, complex I 
supported OXPHOS (PI) respiration, complex I+II supported OXPHOS (PI+II) respiration, 
maximal electron transfer system (ETS) capacity with substrates for complex I and II (EI+II), and 
ETS with substrates for complex II (EII). (B) Respiratory flux control ratios were determined as an 
estimation of leak and OXPHOS capacity within the ETS capacity. (C) Complex I (CI) control 
factor measured as PI+II minus EII respiration, and Complex II (CII) control factor measured as PI+II 
minus PI. Data presented as Mean and SD; n=47 for Caucasian and n=8 for African Americans. 
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Table 3. Bivariate correlation of mitochondrial respiration and fiber type distribution 
  LI PI PI+II EI+II EII 
Type I 0.118 0.025 0.154 0.178 0.234* 
Type IIa -0.205 0.123 -0.055 -0.067 -0.098 
Type IIx 0.070 -0.068 -0.095 -0.052 -0.123 
Type II -0.133 -0.017 -0.193 -0.194 -0.259 
* p<0.05, n= 43. Abbreviations: LI (complex I supported leak respiration), PI (complex I 
supported OXPHOS respiration), PI+II (complex I+II supported OXPHOS respiration), EI+II 
(maximal electron transfer capacity with substrates for complex I and II), and EII (maximal 
electron transfer capacity with complex II substrates only).  
 
 
Table 4. Bivariate correlation of mitochondrial respiration with age, BMI and VO2max 
   LI PI PI+II EI+II EII 
 Age -0.279* -0.198* -0.227* -0.305* -0.195* 
With YA BMI -0.236* -0.428* -0.358* -0.354* -0.376* 
 VO2max  0.300*  0.274*  0.281*  0.311*  0.258* 
 Age -0.200*    -0.011    -0.092    -0.247    -0.030 
Without YA BMI   -0.100    -0.382*    -0.326*    -0.301*    -0.243* 
 VO2max   0.225*     0.142     0.211  0.287*     0.103 
* p<0.05; n= 59 for analysis with YA and n=50 for analysis without YA. Abbreviations: YA 
(Young Active subjects), BMI (body mass index), LI (complex I supported leak respiration), PI 
(complex I supported OXPHOS respiration), PI+II (complex I+II supported OXPHOS respiration), 
EI+II (maximal electron transfer capacity with substrates for complex I and II), and EII (maximal 
electron transfer capacity with complex II substrates only). 
 
 
Table 5. Bivariate correlation of age, BMI and cardiorespiratory fitness 
 Age BMI VO2max 
Age 1 0.057 -0.525* 
BMI - 1 -0.082 
VO2max - - 1 
* p<0.05, n=67-68.
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Table 6. Multiple linear regression investigating the association of BMI, VO2max, and age on mitochondrial respiration 
 Predictor 
LI PI PI+II EI+II 
R2 p R2 p R2 p R2 p 
With YA 
 
BMI+VO2max 0.311 <0.001* 0.453 <0.001* 0.359 <0.001* 0.411 <0.001* 
Age after controlled for BMI+VO2max 0.068 0.020* 0.003 0.540 0.014 0.289 0.052 0.029* 
Without YA 
 
BMI+VO2max 0.271 0.001* 0.207 0.005* 0.122 0.05* 0.164 0.018* 
Age after controlled for BMI+VO2max 0.046  0.093 0.003   0.669 0.002   0.751 0.052 0.093 
*p<0.05, n= 59 for analysis with YA and n=50 for analysis without YA. Abbreviations: YA (Young active subjects), BMI (body mass 
index), LI (complex I supported leak respiration), PI (complex I supported OXPHOS respiration), PI+II (complex I+II supported 
OXPHOS respiration), and EI+II (maximal electron transfer capacity with substrates for complex I and II). 
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Figure 6. Association between mitochondrial respiration with BMI and VO2max. 
Bivariate correlation between complex I supported Leak (LI) respiration with BMI (A) and 
VO2max (B), complex I+II supported OXPHOS (PI+II) respiration with BMI (C) and VO2max (D), 
and maximal electron transfer capacity (EI+II) with BMI (E) and (F) VO2max. Black circles 
represent young active subjects and white circles represent sedentary subjects, n=58-59.  
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2.4.4 Protein expression 
The sedentary groups had reduced levels of OPA1 compared to the YA group (Figure 7A; p<0.05). 
Additionally, the sedentary MAS and OS groups presented lower levels of MFN2, FIS1 and DRP1 
protein expression compared to YA (Figures 7A, B; p<0.05). The MAS group had lower 
expression of beclin-1 compared to the YA (Figure 7C; p<0.05), while there were no differences 
in BNIP3 and LC3-II/LC3-I ratio between the groups (Figure 7C; p>0.05). When examining only 
the sedentary groups, there were no group differences for the proteins measured, except for DRP1. 
MAS group had a reduced level of DRP1 compared to YS (Figure 7B; p<0.05). 
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Figure 7. Expression of quality control proteins and OXPHOS complexes. 
Western blot analysis of; (A) mitochondrial fusion proteins; (B) fission proteins; (C) autophagy 
proteins; and (D) mitochondrial content (OXPHOS, complexes I-V and Total). Values were 
normalized to α-tubulin and a loading control. Data are presented as Mean and SD for figures A, 
B, and C, and as Mean and SE for figure D. Results are expressed as arbitrary units (AU); Vertical 
and horizontal dividing lines were used in the western blot images to present lanes from the same 
gel that were reorganized for presentation purpose; n=5-17 per group. *p<0.05 vs. YS, MAS, and 
OS **p<0.05 vs. MAS and OS, ***p<0.05 vs. MAS, § p<0.05 vs. YS, §§ p<0.05 vs. YA and YS. 
47 
 
 
Quality control protein expression was not associated with age (Table 7). The expression 
of mitochondrial fusion proteins OPA1 and MFN2 (Figure 8A, B), fission proteins FIS1 and DRP1 
(Figure 8C, D), and autophagy proteins Beclin-1 and BNIP3 correlated negatively with BMI 
(Table 7, p<0.05). Similarly, among the sedentary groups only, we found that OPA1, MFN2, FIS1 
and Beclin-1 were also negatively correlated with BMI (Table 7, p<0.05). The findings of this 
study suggest that the capacity for mitochondrial fission, fusion and autophagy is preserved during 
chronological aging per se, but it is influenced by cardiorespiratory fitness and BMI. Interestingly, 
both fission and fusion proteins correlated with BMI, suggesting that increased BMI influences 
the capacity for both processes in sedentary individuals. Additionally, expression of fusion, fission, 
and autophagy proteins were correlated with several mitochondrial respiratory states (Table 8, 
p<0.05). 
 
Table 7. Bivariate correlation of quality control proteins with age, BMI and VO2max 
  OPA1 MFN2 FIS1 DRP1 Beclin-1 BNIP3 LC3II/I 
With YA Age -0.039 -0.111 -0.081 -0.223* -0.058 -0.025 -0.060 
 
BMI -0.360* -0.378* -0.320* -0.288* -0.352* -0.186 -0.086 
VO2max 0.068 0.136 0.117 0.135 0.078 -0.077 -0.087 
Without YA Age 0.147 0.007 0.021 -0.068 0.027 0.006 -0.108 
 
BMI -0.264* -0.310* -0.242* -0.166 -0.460* -0.171 -0.200 
VO2max -0.169 -0.005 0.002 -0.068 -0.059 -0.162 -0.043 
* p<0.05, n= 35-42 for analysis with YA and n=30-36 for analysis without YA. Abbreviations: 
YA (Young active subjects) and BMI (body mass index).  
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Figure 8. Association between mitochondrial fusion and fission proteins with BMI. 
Bivariate correlation of mitochondrial proteins (A) OPA1, (B) MFN2, (C) FIS1 and (D) DRP1 
with BMI. Results are expressed as arbitrary units (AU). Black circles represent young active 
subjects and white circles represent sedentary subjects n=34-41. 
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Table 8. Bivariate correlation of mitochondrial respiration and quality control proteins 
 LI PI PI+II EI+II EII 
OPA1 0.232    0.421*    0.347*    0.305* 0.301* 
Mfn2   0.261*        0.227        0.305*    0.265* 0.266* 
Fis1   0.278*        0.302*        0.242        0.217 0.274* 
DRP1        0.064        0.367*        0.306*        0.161       0.138 
Beclin1   0.276*        0.384*        0.333*     0.314* 0.262* 
* p<0.05, n=35-42. Abbreviations: LI (complex I supported leak respiration), PI (complex I 
supported OXPHOS respiration), PI+II (complex I+II supported OXPHOS respiration), EI+II 
(maximal electron transfer capacity with substrates for complex I and II), and EII (electron 
transfer capacity with substrates for complex II only). 
 
The expression of complex I and V protein was lower in the MAS compared to YS group 
(Figure 7D; p<0.05). Complex III protein was lower in the sedentary groups compared to YA 
(Figure 7D; p<0.05). Total OXPHOS protein content was lower in the MAS when compared to 
the YA and YS groups (Figure 7D; p<0.05). 
2.5 DISCUSSION 
Deeper interrogation into mitochondrial function in aging is crucial to better delineate 
mitochondria as a feasible therapeutic target for sarcopenia and loss of physical function. We 
measured several aspects of substrate-supported respiration and respiratory control parameters, 
along with markers of electron transport chain content and quality control in human muscle 
ranging from 21 to 88 years of age. Our main finding was that maximal rates of mitochondrial 
respiration, and capacity for fusion, fission, and autophagy are not altered with chronological age 
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per se, but that cardiorespiratory fitness and BMI play a more dominant role in explaining the 
apparent age associated changes. 
There have been many reports describing lower mitochondrial oxidative capacity with 
aging (11, 13, 41, 52, 55, 123), however, the majority have not controlled for important covariates 
such as cardiorespiratory fitness (13, 123) and BMI (41, 55, 123). Many have also used isolated 
mitochondria (11, 13, 41). Tonkonogi et al. found lower mitochondrial respiration with age, when 
compared 8 young (22-31yrs) and  7 old (61-86yrs) sedentary subjects matched for physical 
activity levels (55). Despite matching groups for the degree of physical activity, the older subjects 
had lower cardiorespiratory fitness by VO2max (55). However, no information on participants’ 
body composition was presented, which could contribute and partially explain the lower 
mitochondrial respiration in the older group. Similarly, a recent study using permeabilized 
myofibers also reported decreased respiratory capacity and coupling control in older adults 
(62±8yrs, n=31) compared to young (28±7yrs, n=24) subjects (123). However, direct 
measurements of participants’ cardiorespiratory fitness were not collected, and the groups were 
unbalanced for BMI with the older group presenting with increased body fat and higher BMI when 
compared to the young group. Without controlling for these covariates it is difficult to confirm 
whether the lower levels of mitochondrial respiration observed in the old group are due to age per 
se, or are related to differences in cardiorespiratory fitness and body composition. 
A number of studies performed in permeabilized myofibers have failed to find age-related 
changes in mitochondrial respiration (17, 124, 125). Hutter et al. (2007) reported full preservation 
of mitochondrial respiration in older subjects when compared to young men and women (17). 
While cardiorespiratory fitness was not controlled for in the study, a significant correlation 
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between percent body fat and mitochondrial respiration was observed, suggesting that 
mitochondrial respiration is more related to changes in body composition rather than age. 
Similarly, Larsen et al. (2012) reported no differences in mitochondrial respiration between 10 
young (23±3yrs) and 10 middle-aged (53±3yrs) subjects matched for VO2max and BMI (124).  
Our study is the first to investigate associations between mitochondrial respiration and 
quality control in a reasonably large number of subjects (n=68) with a wider range of age (21-
88yrs) and BMI (19-47kg/m2), and to examine the influence of cardiorespiratory fitness and BMI 
on these associations. We found that cardiorespiratory fitness (VO2max) and adiposity (BMI) 
heavily influenced mitochondrial respiratory capacity, and that when controlled for these variables 
no age-related changes in mitochondrial respiration was observed in the sedentary groups. These 
observations are in line with and extend the findings that physical activity levels and 
cardiorespiratory fitness are confounders of the relationship between age and mitochondrial 
respiration (18, 52, 124). The influence of BMI is also supported by others that found reduced 
capacity for lipid oxidation and activity of mitochondrial enzymes in obese subjects (68, 69). The 
relationship between BMI and reduced mitochondrial capacity may be due to the interplay between 
adiposity and the development of insulin resistance and mitochondrial dysfunction (134) or simply 
to the lack of physical activity and/or other lifestyle factors. More research is needed to elucidate 
the intricacies of this relationship.  
We also examined mitochondrial respiratory control ratios/factors. This approach permits 
a qualitative comparison of respiratory performance independent of mitochondrial content, 
methods used to prepare the mitochondria, and variations in assay conditions (135). We found 
higher CI and CII control factors in the YA when compared to the sedentary groups. These control 
factors express the relative change of O2 flux in response to a transition of substrate availability in 
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a defined coupling state (136). CI control factor is experimentally induced when rotenone 
(complex I inhibitor) is added to CI+II-linked respiration and CII control factor when succinate is 
added to Complex I-linked respiration. The sedentary groups had a reduced CI and CII control 
factors, compared to the YA group, suggesting that regular physical activity is linked with oxygen 
flux through complex II and the individuals’ ability to increase O2 flux through complex II in 
response to a transition of substrate availability, independent of overall mitochondria content.   
To determine the association between age and capacity for mitochondrial quality control, 
we measured several proteins that mediate mitochondrial fusion, fission, autophagy and 
mitophagy. The expression of these proteins were not influenced by age in the sedentary group 
while the young active individuals had elevated levels of fusion and fission proteins. These 
findings suggest that physical activity is linked with the capacity for mitochondrial turnover. Our 
results are in line with other studies that reported no age-related differences in mitochondrial fusion 
and fission (14, 137, 138) and autophagy proteins (139) suggesting that these processes are still 
intact in healthy sedentary individuals. Some studies also included an exercise intervention that 
reduced LC3BII/LC3BI in both old and young after an acute bout of resistance exercise (139) and 
reduced FIS1 and MFN after acute aerobic exercise (137). Additionally, aerobic exercise training 
resulted in an elevation of MFN1, MFN2 and FIS1 protein levels in both young and old subjects 
(138). Taken together, these findings suggest that mitochondrial quality control proteins are 
uninfluenced by age and respond to both acute aerobic and resistance exercise and chronic aerobic 
exercise training. Recent animal studies have expanded on the contribution of these processes in 
regulating exercise adaptations. Caffin et al. found OPA1 deficient mice have impaired exercise 
training induced mitochondrial biogenesis (140) and Lira et al. report that an increase in basal 
autophagy is required for metabolic adaptations induced by exercise training (141). These studies 
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indicate that mitochondrial quality control processes are likely involved and important for the 
remodeling of mitochondria in response to exercise. Interestingly, we also found significant 
associations between the expression of fusion, fission, and autophagy proteins with BMI and 
several mitochondrial respiratory states. These results suggest that alterations in mitochondrial 
quality likely play a significant role in maintaining mitochondrial function.  
We acknowledge that multiple comparisons were performed in this study in order to 
investigate the association between chronological age and several respiratory states (total of 11) 
and mitochondrial proteins (7 proteins related to quality control and 5 complexes of mitochondrial 
content). However, we opted to not statistically control for multiple comparisons due to the 
exploratory nature of the study. 
2.5.1 Limitations 
While our results suggest that body mass index and VO2max are more strongly associated with 
changes in mitochondrial capacity than age per se, we acknowledge that the use of a cross-sectional 
design limits the interpretation of the findings. Future longitudinal studies that investigate whether 
changes in body composition and cardiorespiratory fitness are concomitant with changes in 
mitochondrial capacity will be essential. Moreover, mitochondrial capacity was evaluated ex vivo 
through analysis of mitochondrial respiration, and expression of proteins related to mitochondrial 
dynamics and content. While analysis of mitochondrial respiratory capacity in permeabilized 
myofibers through high-resolution respiration is the gold standard method for investigating 
mitochondrial respiration, we acknowledge that use of an ex vivo approach may not completely 
represent the in vivo characteristics.  
54 
 
It is also important to highlight that BMI was used as an indicator of body fat and obesity, 
and it is not a direct measure of body fatness, and for an equivalent BMI, older subjects have a 
higher percentage body fat than young subjects (142). Future studies using direct measures of body 
fat, such as dual-energy x-ray absorptiometry (DEXA), would provide essential information on 
the influence of body fat, and its distribution to mitochondrial capacity in aging.  
Another limitation of this study is the fact that the different age groups presented specific 
characteristics that were important for the parent study. First, the majority of the subjects were 
sedentary and only the young group included active subjects. The inclusion of active individuals 
in the middle-aged and older groups would provide important information on whether physical 
activity also influences the association between mitochondrial capacity and chronological age at 
these ages. Additionally, while the studies that included young and middle-aged subjects were 
specifically designed to include obese subjects, the old group only included two obese subjects. 
The old group only presented subjects in good general health and excluded individuals that had 
significant cardiovascular, neurological, and musculoskeletal conditions that would affect their 
lower limb extremity function. Future studies should also include older adults with a wide range 
of health, including subjects that are obese.  
2.6 CONCLUSION 
Mitochondrial respiratory capacity and expression of mitochondrial quality control proteins are 
elevated in young physically active individuals, but are similar among sedentary young, middle-
aged and older subjects. Our findings suggest that mitochondrial capacity is not influenced by 
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chronological age per se, but is more closely related to BMI and cardiorespiratory fitness. Our data 
provide strong evidence that confounding factors of mitochondrial function, such as adiposity, 
cardiorespiratory fitness are critical phenotypic characteristics that should be considered in studies 
of aging muscle. This is essential if we are to provide clarity on the true nature of mitochondrial 
dysfunction with aging which in turn will allow us to more accurately develop mitochondrial 
targeted therapeutics in aging. 
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3.0  ASSOCIATION OF MITOCHONDRIAL RESPIRATION WITH MYOFIBER 
CROSS-SECTIONAL AREA, INTRAMYOCELLULAR LIPID CONTENT, AND 
PHYSICAL FUNCTION IN A GROUP OF VERY OLDER ADULTS 
3.1 SUMMARY 
While several factors have been associated with the onset and development of sarcopenia, the 
primary mechanisms contributing to this age-related decrease in muscle mass and strength remain 
to be clarified. This cross-sectional study sought to determine the influence of mitochondrial 
respiration on myofiber cross-sectional area as a measure of muscle size, intramyocellular lipid 
content, and physical function in a group of very old subjects. We hypothesized that mitochondrial 
respiratory capacity would be negatively associated with intramyocellular lipid content, and 
positively associated with myofiber cross-sectional area and physical function. Methods: 
Percutaneous biopsies of the vastus lateralis were obtained from 41 very old subjects (85-95yrs). 
Mitochondrial respiration was determined in saponin permeabilized myofiber bundles. Type I, IIa 
and IIx myofiber cross-sectional area and intramyocellular lipid content were evaluated 
histologically. Grip strength was tested by a handheld dynamometer, and knee extension torque 
was evaluated by an isokinetic dynamometer. Physical performance was evaluated by a series of 
physical function tests including the multiple chair stand, standing balance, 6-meter walk, and 20-
meter walk tests. Results: Mitochondrial respiration were not associated with myofiber cross-
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sectional area and intramyocellular lipid content. Complex I supported maximal OXPHOS 
respiration explained 19% of the variance in knee extensors peak torque, and mitochondrial 
respiration explained 11-14% percent of variation in grip strength, after controlling for age, sex, 
race, and BMI. Additionally, mitochondrial respiration was associated with preferred gait speed 
tested on the 6 and 20-meter walk tests. Conclusions: Skeletal muscle mitochondrial respiration 
is associated with measures of physical function in very older adults.  
3.2 INTRODUCTION 
Sarcopenia, the age-related decline in skeletal muscle mass and strength, is a well-established risk 
factor for several negative health-related conditions including disability, frailty, 
institutionalization, and mortality (23). While cellular, systemic and lifestyle factors have shown 
to be associated with the onset and development of sarcopenia, the primary mechanisms 
contributing to this process are still uncertain. Additionally, longitudinal studies have shown that 
the age-related changes in muscle mass do not correspond to the changes in muscle strength (119, 
143). The dissociation between changes in muscle mass and strength suggests that other underlying 
factors such as cellular, neural, and metabolic features influence the age-related loss of muscle 
strength.  
Among the cellular factors hypothesized to play a role on sarcopenia is mitochondrial 
function. Recent animal studies have provided strong evidence that there is a mechanistic link 
between loss of muscle mass and strength with mitochondrial capacity (19, 20, 36, 37, 144). These 
studies have shown that mitochondrial dysfunction plays a major role on sarcopenia through 
alterations in several processes such as apoptosis (144), and autophagy (19), and that mitochondrial 
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dysfunction is associated with age-related muscle atrophy (19, 20), and decreases in muscle 
strength (19) and performance (36, 37).  
Despite the large number of animal studies supporting the influence of mitochondria on 
sarcopenia, few have provided evidence of this relationship in humans. A recent study performed 
by Gouspillou and colleagues have shown that mitochondrial-mediated apoptotic signaling is 
increased in muscle from older individuals (62). The authors suggest that accumulation of 
dysfunctional mitochondria with exaggerated apoptotic sensitivity is due to impaired mitophagy 
(62). Additionally, some recent cross-sectional human studies have shown an association between 
mitochondrial dysfunction and physical function in older adults. A study comparing 10 active and 
10 sedentary older adults showed that the sedentary group presented a lower mitochondrial 
capacity as well as reduced fat-free mass, maximal isometric torque, and poorer performance on 
the walk test and stair-climb test when compared to active older adults (18). A previous study 
conducted by our research group has shown that mitochondrial efficiency is associated with 
preferred walking speed (22). Likewise, mitochondrial respiration have shown to be reduced in 
low-functioning elderly, determined by the short physical performance battery (SPPB) score, when 
compared to high-functioning elderly (14).  
This study sought to determine the association between mitochondrial respiration with 
myofiber cross-sectional area as a measure of muscle size, intramyocellular lipid content and 
physical function in a group of 41 very old subjects (85 to 95yrs). We hypothesized that 
mitochondrial respiratory capacity would be negatively associated with intramyocellular lipid 
content, and positively associated with myofiber cross-sectional area and physical function.  
The results of the present study will complement the previous findings by: 1. using a group 
of very old individuals (85-95yrs), in which decreases in muscle mass and physical function are 
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pronounced and the associations with sarcopenia more likely to be established, 2. investigating the 
association between mitochondrial capacity and muscle size at the cellular level, and 3. by 
comprehensively investigating the association between mitochondrial capacity and physical 
function, using several measures of muscle strength, balance and physical performance. 
3.3 METHODS 
3.3.1 Study design 
This ancillary cross-sectional study was designed to include a group of subjects participating at 
the Year 16 examination of the Dynamics of Health, Aging and Body Composition (Health ABC) 
study, Pittsburgh site. The Health ABC study is a longitudinal cohort study investigating factors 
that contribute to disability in the elderly, with special focus on body composition and weight-
related health conditions. The study targeted to understanding the decline in function of healthier 
older persons, and the transition from vigor to frailty. The Health ABC study recruited 3,075 men 
and women with aged between 70-79yrs. All persons in the study were selected to be free of 
disability in activities of daily living and free of functional limitation (defined as any difficulty 
walking a quarter of a mile or any difficulty walking up 10 steps without resting) at baseline.  
3.3.2 Subjects 
A subset of forty-one older men and woman currently enrolled at The Health ABC study who were 
found to be eligible for the Year 16 examination and agreed to have a percutaneous muscle biopsy 
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performed were invited to be part of this sub-study. Subjects were included in the study if they had 
no known cognitive impairment, as defined by taking a medication for the treatment of dementia 
or scoring <20 on a phone telephone interview for cognitive status (TICS), live in the area, and do 
not reside in a nursing home. Additionally, a screening interview was done over the phone to 
determine if the participant was eligible for a percutaneous muscle biopsy.  
Subjects were not tested for knee extension torque if they presented with any of the 
following conditions: history of cerebral aneurysm, cerebral bleeding within the past six months, 
blood pressure higher than 199/109mmHg, severe bilateral knee pain that would make the 
examination uncomfortable. Participants with severe unilateral knee pain, or that had previous 
unilateral total knee replacement, were tested on the opposite side. Similarly, exclusion from the 
performance tests was based on an individualized assessment of impairments and safety concerns. 
All subjects provided written informed consent and the study was approved by the University of 
Pittsburgh Institutional Review Board. 
3.3.3 Outcome measures 
Participants had two clinic visits for data collection. The first visit was at the University of 
Pittsburgh’s Health Studies Research Center, where physical function was evaluated. The second 
visit was at the University of Pittsburgh’s Clinical Translational Research Center, and a 
percutaneous muscle biopsy was collected for analysis of myofiber cross-sectional area, 
intramyocellular lipid (IMCL) content, and mitochondrial respiratory capacity. 
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3.3.4 Physical function  
Physical function was evaluated through analysis of grip strength, knee extension torque, and a 
battery of tests including: multiple chair stands, standing balance, 6-meter balance walk, and 20-
meter walk tests. All the performance based measurements were administered by a certified 
examiner, which demonstrated each maneuver for the participant before the test. Practice trial and 
rest between tasks were allowed if participants were fatigued during the assessments. 
3.3.4.1 Grip strength 
Handgrip strength (kg) was measured using a hand-held dynamometer (Jamar; TEC, Clifton, NJ), 
which has shown to be a valid and reliable approach (ICC=0.91-0.94) (145, 146). The test was 
performed with the participant in a seated position with the arm to be tested resting on a table and 
the elbow held at approximately a right angle. Subjects were instructed to squeeze the hand 
maximally. Grip size was adjusted for each participant, and one submaximal practice trial was 
performed to determine if the procedure was understood. Two trials were performed with a 15 to 
20 seconds rest between trials. Average values for the right hand were used.  
3.3.4.2 Isokinetic knee extension 
Isokinetic knee extension was assessed using the Kin-Com 125 AP Isokinetic Dynamometer. After 
instrument calibration, subjects were shown how the task should be performed. Participants were 
seated in an upright position and were stabilized with straps across the pelvis and the distal thigh 
of the leg performing the task. The axis of the dynamometer was positioned so that it was aligned 
with the axis of rotation of the knee. To correct for gravity, participant's limb were weighed at 
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approximately 45°. Start and stop angles were set at 90° and 30°. Before testing begins, participants 
were asked to perform a maximum isometric effort to determine the starting force for the isokinetic 
dynamometry. The test starting force was set at half the maximum isometric effort. Participants 
were instructed to perform two good submaximal practice efforts before testing begin to ensure 
that the subject understood and was familiar with the task. For the data collection, subjects were 
instructed to perform a maximal effort with each contraction. Standard encouragement (verbal 
motivation and visual feedback) was given. Performance of knee extensors was tested at 60°/sec. 
Concentric efforts were repeated until three similar curves have been obtained, with a 20-second 
rest between each trial. The highest value obtained during the test was considered the knee 
extension peak torque and was used for analysis.  
3.3.4.3 Multiple chair stand 
Participants were instructed to stand up from a seated position and sit back down in the chair, 
without using their arms, five times as quickly as possible. The time subjects took to complete the 
task was recorded. The multiple chair stand test is a valid measure of dynamic balance and 
functional mobility, and has an excellent reliability (ICC=0.95) (147). 
3.3.4.4 Standing balance 
A series of timed, progressively more difficult, static balance tests was performed. The time (up 
to 30 seconds) the participant was able to hold each of the test positions (semi-tandem, tandem, 
and one-legged stands) were recorded. Subjects were allowed to try a second trial on the tandem 
stand and one-leg stand positions if they were not able to attain the positions, or attained the 
position for less than 30 seconds. The best performance in each one of the positions was used in 
the analysis.  
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3.3.4.5 Balance walk 
Preferred gait speed was evaluated using the 6-meter walk test. In addition, gait speed was also 
evaluated with the subject walking along a narrowed path (20 cm). The narrowed walk path was 
designed to make the participant slow down during gait with a narrowed base of support, a situation 
that requires increased motor control. The test was performed up to three trials to obtain 2 valid 
times. The average of two trials were used.  
3.3.4.6 20-meter walk test 
Gait speed was also evaluated at the participant’s usual and fast pace during a 20-meter walk test.  
3.3.5 Skeletal muscle biopsy 
Percutaneous muscle biopsies were obtained at the University of Pittsburgh Clinical Translational 
Research Center on a morning after an overnight fast. Participants were instructed not to perform 
physical exercise 48 hours prior to the biopsy procedure. Briefly, muscle biopsies were collected 
under local anesthesia (2 % buffered lidocaine) from the middle region of the vastus lateralis using 
a 5 mm muscle biopsy Bergström cannula (Stille Surgical instruments, Eskilstuna, Sweden), as 
previously described (132, 148). Immediately after the biopsy procedure the specimen was blotted 
dry and trimmed of visible adipose tissue using a standard dissecting microscope (Leica EZ4, Leica 
Microsystems, Switzerland). A portion of the specimen (~15mg) was placed in ice-cold BIOPS 
media (22) for analysis of mitochondrial respiratory capacity. A second portion was processed for 
histochemistry (30-40mg) and stored at -80 °C. 
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3.3.6 Myofiber cross-sectional area and intramyocellular lipid content 
Histochemical analyses were performed on serial sections using methods previously described 
(93). Briefly, biopsy samples were sectioned (10 m) on a cryostat (Cryotome E; Thermo Shandon, 
Pittsburgh, PA) at -20 °C and placed on individual pre-cleaned glass slides (Fisherfinest, Fischer 
Scientific, Pittsburgh, PA). Sections were stained in a filtered solution of Oil Red O (300mg/ml in 
36% triethylphosphate) for 30 minutes at room temperature. Thereafter, sections were incubated 
with primary antibodies for anti-human myosin heavy chain (MYH)-7 (type I myocytes), and 
MYH-2 (type IIa myocytes) (Santa Cruz Biotechnologies, Santa Cruz, CA) overnight at room 
temperature. Samples were then incubated with rhodamine (type I myocytes) and fluorescein 
(FITC) (type IIa myocytes) conjugated secondary antibodies (Santa Cruz Biotechnologies, Santa 
Cruz, CA). Type IIx fibers remained unstained. Images were visualized using a Leica microscope 
(Leica DM 4000B; Leica Microsystems, Bannockburn, IL), digitally captured (Retiga 2000R 
camera; Q Imaging, Surrey, Canada), and analyzed using specialized software (Northern Eclipse, 
v6.0; Empix Imaging, Cheektowaga, NY).  
3.3.7 Mitochondrial respiration 
Immediately after the biopsy procedure, permeabilized myofiber bundles were prepared. Briefly, 
myofiber bundles were gently teased apart in a petri dish containing ice-cold BIOPS solution using 
2 sharp tweezers and a dissecting microscope (Leica Microsystems, Heerbrugg, Switzerland). The 
myofiber bundles were then permeabilized with saponin (2 mL of 50 ug/mL saponin in BIOPS 
solution) for 20 minutes at 4°C on an orbital shaker, and then washed twice for 10 minutes at 4°C 
with MIR05 respiration medium (22).  
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Mitochondrial respiratory capacity in permeabilized myofibers was evaluated by high-
resolution respirometry (Oxygraph-2k, Oroboros Instruments, Innsbruck, Austria), as shown on 
figure 2. Measurements were performed in duplicate, at 37°C, in the range of 230-150 nmol O2/ml. 
LEAK (LI) respiration was determined through the addition of pyruvate (5mM), malate (2mM) 
and glutamate (10mM). ADP (5mM) was added to elicit complex I supported OXPHOS (PI) 
respiration. Cytochrome c (10 μM) was added to check the quality of the muscle fiber preparation 
and assess the integrity of the outer mitochondrial membrane. Any sample that showed an increase 
in respiration of more than 15% with the addition of cytochrome c was not included in the final 
analysis. Succinate (10mM) was then added to elicit complex I+II supported OXPHOS (PI+II). 
FCCP (1uM) was added to determine electron transfer system (ETS) capacity or maximal 
uncoupled respiration. Finally, rotenone (1µM) was added to inhibit complex I supported 
OXPHOS respiration, and the remaining respiration revealed the maximal ETS capacity with 
complex II substrates only (EII). Following the assay, myofiber bundles were recovered, dried, and 
weighted on an analytical balance (Mettler Toledo, XS105). Steady state O2 flux for each 
respiratory state was determined and normalized to myofiber bundle dry weight using Datlab 4 
software (Oroboros Instruments, Innsbruck, Austria). 
Respiratory control ratios/factors were calculated to investigate intrinsic mitochondrial 
respiratory capacity. Since the different respiratory states were evaluated in the same myofiber 
bundle, and therefore same population of mitochondria, this approach is a valuable method to 
estimate mitochondrial function/quality independent of mitochondrial content, quality of myofiber 
bundle preparation and unintentional variation in assay conditions (123). Respiratory acceptor 
control ratios were calculated as PI/LI and PI+II/LI. Considering maximal uncoupled respiration 
(EI+II) as an internal measure of the ETS capacity, flux control ratios were calculated for leak 
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respiration (LI/EI+II), complex I supported OXPHOS respiration (PI/EI+II), and complex I+II 
supported OXPHOS respiration (PI+II/EI+II). The results from the flux control ratios offer an 
estimation of the leak and OXPHOS capacity within the ETS capacity. Complex I (CI) and 
complex II (CII) control factors were calculated to investigate the relative change of O2 flux in 
response to a transition of substrate availability in a defined coupling state. CI control factor 
corresponds to the difference between complex I+II supported OXPHOS respiration and EII 
respiration. CII control factor corresponds to the difference between complex I+II supported 
OXPHOS respiration and complex I only supported OXPHOS respiration.  
3.3.8 Statistical analysis 
Multiple linear regressions were performed to investigate the association of mitochondrial 
respiration with sarcopenia. Myofiber cross-sectional area, intramyocellular lipid content, and 
measures of physical function were considered dependent variables. Separate multiple linear 
regression models were built for each dependent variable. Age, sex, race, and BMI were controlled 
in the models since these variables were associated with either the dependent or independent 
variables. Assumptions for the use of multiple linear regression were checked. Variables not 
normally distributed were transformed when necessary. The contribution of mitochondrial 
capacity to the outcome variables was assessed by the magnitude and significance of R2 change. 
No adjustment was made for multiple comparisons because of the exploratory nature of the study. 
The association between the standing balance variables and mitochondrial respiration was tested 
by spearman partial correlation, adjusting for age, BMI, sex and race. We opted for analyzing the 
standing balance with spearman partial correlation, instead of multiple linear regression, because 
even after data transformations residuals were still not normally distributed.  
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In addition to using multiple linear regression to test the association between mitochondrial 
respiration and measures of sarcopenia, we further explored these associations by ranking the 
results of PI+II respiration and splitting the scores into tertiles. Subjects in the lower (n=11) and 
higher (n=11) tertiles of mitochondrial respiration were compared for myofiber cross-sectional 
area, intramyocellular lipid content and physical function using independent t-test or Mann-
Whitney U, as appropriate. Analyses were performed using SPSS v22.0 software (Armonk, NY). 
Statistical significance was established, a priori, at p≤0.05.  
3.3.9 Power calculation 
To test the study hypothesis at an alpha level of 0.05, with a sample size of 40 subjects, this study 
had 81% power to detect an effect size (r) of 0.42. Additionally, at an alpha level of 0.05, with a 
sample size of 40 subjects, this study had 80% power to detect an R-square of 22% attributed to 
the 4 covariates and mitochondrial respiration accounting for an additional 15% of the variability. 
Power calculation was performed using G*Power 3.1 and SPSS SamplePower 3.0 software. 
3.4 RESULTS 
3.4.1 Participant characteristics 
A total of 216 potential participants were screened by telephone interview. Of those interviewed, 
47 were not eligible for muscle tissue collection and 105 were not interested in participating in the 
study. Out of the 64 participants that were eligible to participate in this study, 41 had a muscle 
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biopsy collected (Figure 9). The participant characteristics can be found in table 9. A total of 16 
men and 25 women, with age between 85 and 95 years participated in this cross-sectional study. 
The group had a wide range of BMI (16-36 Kg/m2), including 1 subject that was underweight and 
2 subjects that were severely obese. A wide range of physical performance was also presented 
(Table 9).  
 
 
Figure 9. Participant flowchart 
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Table 9. Descriptive data for participants of study 2 
Sex Male Female p value 
Age (yrs) 88.3 ± 2.7 (85-95) 88.5 ± 2.3 (85-93) 0.80 
Weight (Kg) 75.2 ± 12.2 (62.7-110.4) 69.3 ± 13.3 (39-88.8) 0.16 
BMI (Kg/m2) 26.5 ± 3.0 (22.5-35.2) 28.1 ± 4.7 (16.5-36.5) 0.23 
Race C = 12, AA = 4 C = 15, AA = 10 - 
Grip strength (kg) 28.9 ± 6.4 (18-45) 18.6 ± 5.7 (10-33) <0.01* 
Knee extension peak torque (Nm) 93.8 ± 13.5 (73-114), n=11 70.1 ± 23.8 (26-106), n=18   0.01* 
Multiple chair stands (s) 13.1 ± 2.7 (9.5-19.6), n=13 14.4 ± 4.7 (7.1-24.8), n=21 0.38 
Standing balance (s)   - 
                                      Semi-tandem stand                        25.7 ± 10.5 (0-30), n=15 23.4 ± 12.0 (0-30), n=25 0.55 
                                      Tandem stand 28.9 ± 4.1 (15.25-30), n=13 17.6 ± 12.9 (0-30), n=22 <0.01* 
                                      One leg stand 9.8 ± 10.9 (0-30), n=12 6.4 ± 7.3 (0-30), n=22 0.30 
Gait speed on the 6-meter balance walk (m/s)   - 
                                      Usual pace walk  0.95 ± 0.15 (0.82-1.28), n=13 0.90 ± 0.17 (0.54-1.27), n=20 0.44 
                                      20 cm narrow walk  0.91 ± 0.17 (0.71-1.16), n=6  0.81 ± 0.27 (0.35-1.11), n=10 0.44 
Gait speed on the 20-meter walk (m/s)   - 
                                      Usual pace  1.05 ± 0.16 (0.78-1.43), n=14 1.01 ± 0.21 (0.68-1.46), n=25  0.49 
                                      Fast pace  1.39 ± 0.20 (1.07-1.73), n=14 1.21 ± 0.27 (0.67-1.62), n=25   0.03* 
 Data presented as Mean ± SD (Min-Max). N=16 for male and N=25 for females, unless otherwise stated. 
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3.4.2 Association of mitochondrial respiration with myofiber area, intramyocellular lipid 
content, and physical function 
Several multiple linear regression models were performed to investigate the association of 
mitochondrial respiration with myofiber cross-sectional area, intramyocellular lipid content, and 
physical function. Age, sex, race, and BMI were controlled in the models since they have 
demonstrated to be associated with either mitochondrial respiration or some of the dependent 
variables (Table 9 and 10, and Figures 10, 11, and 12). Mitochondrial respiratory capacity is 
described in table 11. Association between age, BMI and physical function measures are shown in 
table 12. 
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Table 10. Myofiber distribution, cross-sectional area and intramyocellular lipid content 
 Male Female p value 
Fiber Type (%)    
Type I 48 ± 18  43 ± 13  0.29 
Type II 52 ± 18 57 ± 13  0.29 
              Type IIa 40 ± 16 47 ± 12 0.11 
              Type IIx 12 ± 11  10 ± 9 0.51 
Cross-Sectional Area (µm2)    
Type I 4677 ± 1273  3731 ± 1480  0.05* 
Type II 3753 ± 1127  2006 ± 658  <0.01* 
              Type IIa 3730 ± 1105 2135 ± 748  <0.01* 
              Type IIx 3618 ± 1400  1551 ± 600  <0.01* 
Intramyocellular lipid content (AU)    
Type I 5456 ± 1706  6081 ± 1541  0.25 
Type II 3630 ± 1462  3312 ± 1189 0.46 
              Type IIa 3775 ± 1510  3454 ± 1329 0.49 
              Type IIx 2961 ± 1335  3160 ± 1198 0.66 
Data presented as Mean ± SD, n=16 for male and n=22 for female. 
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Figure 10. Mitochondrial respiratory capacity in Caucasians and African Americans. 
(A) Mitochondrial respiration consisting of complex I supported Leak (LI) respiration, complex I 
supported OXPHOS (PI) respiration, complex I+II supported OXPHOS (PI+II) respiration, 
maximal electron transfer system (ETS) capacity with substrates for complex I and II (EI+II), and 
ETS with substrates for complex II (EII). (B) Respiratory flux control ratios were determined as an 
estimation of leak and OXPHOS capacity within the ETS capacity. (C) Complex I (CI) control 
factor measured as PI+II minus EII respiration, and Complex II (CII) control factor measured as PI+II 
minus PI. Data presented as Mean and SD, n=22 for Caucasians and n=11 for African Americans. 
73 
 
Figure 11. Myofiber distribution, cross-sectional area and intramyocellular lipid (IMCL) content in 
Caucasians and African Americans. 
(A) Myofiber distribution. (B) Myofiber cross-sectional area (CSA). (C) Myofiber 
intramyocellular lipid content. Data presented as Mean and SD; * p<0.05, n=25 for Caucasian and 
n=13 for African American. 
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Figure 12. Multiple chair stand and gait speed in Caucasians and African Americans. 
(A) Multiple chair stand (sec); n=20 for Caucasian and n=14 for African American. (B) Gait speed 
on the 20-meter walk test (m/sec); n=26 for Caucasian and n=14 for African American. Data 
presented as Mean and SD. * p<0.05. 
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Table 11. Mitochondrial respiratory capacity 
 Male Female p value 
Complex I supported leak respiration (LI) 29 ± 8  26 ± 10 0.31 
Complex I supported OXPHOS (PI) 133 ± 53  133 ± 50 0.99 
Complex I and II supported OXPHOS (PI+II) 244 ± 75  243 ± 82 0.98 
Complex I and II supported electron transfer capacity (EI+II) 279 ± 94  280 ± 93  0.97 
Complex II supported electron transfer capacity (EII) 144 ± 36  137 ± 40  0.59 
LI/EI+II flux control ratio  0.11 ± 0.05  0.10 ± 0.04  0.24 
PI/EI+II flux control ratio 0.47 ± 0.07 0.48 ± 0.10  0.84 
PI+II/EI+II flux control ratio 0.89 ± 0.08  0.87 ± 0.06  0.51 
Complex I control factor (PI+II – EII) 100 ± 57 107 ± 52  0.72 
Complex II control factor (PI+II – PI) 111 ± 31 110 ± 48  0.96 
 PI/LI Respiratory control ratio  4.7 ± 2  5.3 ± 1.2 0.29 
PI+II/LI Respiratory control ratio 8.7 ± 2.8  10.2 ± 3.1  0.19 
     Data presented as Mean ± SD, n = 13 for male and n=20 for female.  
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Table 12. Correlation matrix of age, BMI, and physical function measures  
 Age  
(years) 
BMI 
(kg/m2) 
Grip Strength 
(Kg) 
Peak Torque 
(Nm) 
Multiple 
Chair Stand 
(Sec) 
Balance  
Semi-tandem 
(Sec) 
Balance 
Tandem  
(Sec) 
Balance  
One-leg stand  
(Sec) 
Age  1 -0.062 -0.036 -0.098 0.230 0.061 0.118 0.020 
BMI   1 -0.004 0.185 0.161 0.124 -0.122 -0.211 
Grip Strength   1 0.559* -0.231 0.375* 0.717* 0.304 
Peak Torque    1 -0.141 0.066 0.285 0.349 
Chair Stand     1 -0.061 -0.411* -0.044 
Semi-tandem      1 0.368* 0.132 
Tandem       1 0.354* 
One-leg stand        1 
Gait speed1         
Gait speed2         
Gait speed3         
Gait speed4         
  
 
 
77 
Table 12. (continued) 
 Gait speed 1 
6-meter walk 
(m/sec) 
Gait speed 2 
6-meter walk, narrow path 
(m/sec) 
Gait speed 3 
20-meter walk, usual pace 
(m/sec) 
Gait speed 4 
20-meter walk, fast pace 
(m/sec) 
Age  -0.088 0.439 -0.280 -0.260 
BMI  0.019 -0.287 -0.224 -0.371* 
Grip Strength 0.294 0.349 0.182 0.366* 
Peak Torque 0.073 0.446 0.064 0.105 
Chair Stand -0.133 0.002 -0.326 -0.496* 
Semi-tandem 0.394* 0.420 0.257 0.261 
Tandem 0.205 0.641* 0.140 0.208 
One-leg stand 0.358 0.549* 0.254 0.153 
Gait speed 1 1 0.632* 0.658* 0.550* 
Gait speed 2  1 0.305 0.032 
Gait speed 3   1 0.613* 
Gait speed 4    1 
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3.4.2.1 Myofiber cross-sectional area   
While age, sex, race, and BMI combined have shown to explain 39-64% of the variance in 
myofiber cross-sectional area (p<0.05, Table 13), mitochondrial respiration (LI, PI, PI+II, EI+II, and 
EII) did not explain a significant additional amount of variation in type I, IIa, IIx, and II myofiber 
cross-sectional area (p>0.05, Table 13), after controlled for these covariates.  
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Table 13. Multiple linear regression investigating the association of mitochondrial respiration and myofiber cross-sectional area 
    Myofiber cross-sectional area (µm2) 
    Type I Type IIa  Type IIx  Type II  
    R2 p R2 p R2 p R2 p 
  Age, sex, race, and BMI 0.394 <0.01* 0.492 <0.01* 0.644 <0.01* 0.558 <0.01* 
LI After controlled for covariates 0.059 0.115 0.005 0.625 <0.001 0.907 0.003 0.686 
PI After controlled for covariates 0.004 0.674 0.002 0.745 0.022 0.253 <0.001 0.998 
PI+II After controlled for covariates 0.048 0.155 0.003 0.693 0.004 0.634 0.001 0.807 
EI+II After controlled for covariates 0.035 0.228 0.004 0.644 0.005 0.603 0.002 0.766 
EII After controlled for covariates  0.022 0.34 0.042 0.147 0.017 0.31 0.033 0.168 
*p<0.05, n=27-31. Abbreviations: BMI (body mass index), LI (complex I supported leak respiration), PI (complex I 
supported OXPHOS respiration), PI+II (complex I+II supported OXPHOS respiration), EI+II (maximal electron transfer 
capacity with substrates for complex I and II), and EII (electron transfer capacity with substrates for complex II only). 
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3.4.2.2 Intramyocellular lipid content 
Mitochondrial respiration (LI, PI, PI+II, EI+II, and EII) did not explain a significant amount of 
variation in type I, IIa, IIx, and II intramyocellular lipid content (p>0.05, Table 14), after 
controlling for age, sex, race, and BMI. 
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Table 14. Multiple linear regression investigating the association of mitochondrial respiration and intramyocellular lipid content 
    Intramyocellular lipid content (AU) 
    Type I Type IIa  Type IIx  Type II  
    R2 p R2 p R2 p R2 p 
  Age, sex, race, and BMI 0.072 0.735 0.174 0.272 0.232 0.196 0.161 0.317 
LI After controlled for covariates  0.021 0.456 0.010 0.585 <0.001 0.975 0.019 0.459 
PI After controlled for covariates 0.020  0.464 0.013 0.532 <0.001 0.940 0.002 0.826 
PI+II After controlled for covariates <0.001 0.972 0.002 0.824 0.026 0.404 0.009 0.609 
EI+II After controlled for covariates  0.005 0.726 0.002 0.820 0.006 0.700 <0.001 0.955 
EII After controlled for covariates  0.027 0.392 0.007 0.652 0.032 0.351   0.015 0.510 
 N=31. Abbreviations: BMI (body mass index), LI (complex I supported leak respiration), PI (complex I supported 
OXPHOS respiration), PI+II (complex I+II supported OXPHOS respiration), EI+II (maximal electron transfer capacity 
with substrates for complex I and II), and EII (electron transfer capacity with substrates for complex II only). 
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3.4.2.3 Grip strength and knee extension torque 
While age, sex, race, and BMI combined explained 50% of the variance in grip strength (p<0.01, 
Table 15), mitochondrial respiration (PI, PI+II, EI+II, EII) explained an additional 11-14% of this 
variance (p<0.05, Table 15). Age, sex, race, and BMI combined explained 31% of the variance in 
knee extension peak torque (P=0.151, Table 15), with PI respiration explaining an additional 19% 
of this variance (p=0.027, Table 15).  
 
Table 15. Multiple linear regression investigating the association of mitochondrial respiration on grip 
strength and knee extension torque 
  
Grip Strength  
(kg) 
Knee extension torque  
(Nm) 
  R2 p R2 p 
 Age, sex, race, and BMI 0.500 <0.01* 0.313 0.151 
LI After controlled for covariates 0.024 0.253 0.055 0.256 
PI After controlled for covariates 0.110  0.010* 0.187   0.027* 
PI+II After controlled for covariates 0.114  0.009* 0.071 0.195 
EI+II After controlled for covariates 0.139  0.003* 0.064 0.218 
EII After controlled for covariates 0.111  0.010* 0.008 0.661 
*p<0.05, n=33 for grip strength and n=22 for knee extension peak torque. Abbreviations: BMI 
(body mass index), LI (complex I supported leak respiration), PI (complex I supported OXPHOS 
respiration), PI+II (complex I+II supported OXPHOS respiration), EI+II (maximal electron transfer 
capacity with substrates for complex I and II), and EII (electron transfer capacity with substrates 
for complex II only). 
 
 
 
 
 
83 
3.4.2.4 Physical performance 
Mitochondrial respiration (LI, PI, PI+II, EI+II, and EII) did not explain a significant amount of 
variance in the results of the standing balance tests (p>0.05, Table 16), multiple chair stand 
(p>0.05, Table 17), and gait speed on the 6-meter walk test (p>0.05, Table 17) and 20-meter walk 
tests (p>0.05, Table 18), after controlling for age, sex, race, and BMI. 
 
Table 16. Spearman partial correlation investigating the association of mitochondrial respiration and 
standing balance tests 
 Semi-tandem stand (sec) Tandem stand (sec) One leg stand (sec) 
LI 0.2108 0.0545 -0.0402 
PI 0.2688 0.2209 0.1577 
PI+II 0.3335 0.1646 0.1728 
EI+II 0.2896 0.1944 0.1699 
EII 0.1778 0.0599 0.3271 
Values represent spearman partial correlation after controlling for age, body mass index, sex and 
race, n=34-40. Abbreviations: BMI (body mass index), LI (complex I supported leak respiration), 
PI (complex I supported OXPHOS respiration), PI+II (complex I+II supported OXPHOS 
respiration), EI+II (maximal electron transfer capacity with substrates for complex I and II), and 
EII (electron transfer capacity with substrates for complex II only)
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Table 17. Multiple linear regression investigating the association of mitochondrial respiration on multiple chair stand and balance walk tests 
    
Multiple chair stand 
(sec) 
6 meter walk 
Gait speed (m/sec) 
6 meter walk (Narrow path) 
Gait speed (m/sec) 
    R2 p R2 p R2 p 
  Age, sex, race, and BMI 0.260 0.141 0.115 0.591 0.107 0.873 
LI After controlled for covariates 0.003 0.768 0.003 0.795 0.005 0.825 
PI After controlled for covariates 0.009 0.615 <0.001 0.989 0.050 0.486 
PI+II After controlled for covariates 0.005 0.701 0.027 0.423 0.046 0.504 
EI+II After controlled for covariates 0.003 0.766 0.014 0.567 0.018 0.667 
EII After controlled for covariates  0.004 0.733 0.101 0.115 0.001 0.907 
N=27 for the multiple chair stand, n=27 for the 6-meter walk test, and n=15 for the 6-meter walk test (Narrow path). 
Abbreviations: BMI (body mass index), LI (complex I supported leak respiration), PI (complex I supported OXPHOS 
respiration), PI+II (complex I+II supported OXPHOS respiration), EI+II (maximal electron transfer capacity with substrates 
for complex I and II), and EII (electron transfer capacity with substrates for complex II only).
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Table 18. Multiple linear regression investigating the association of mitochondrial respiration and gait 
speed on the 20-meter walk test 
  
Gait speed (m/sec) 
Usual pace 
Gait speed (m/sec) 
Fast pace 
  R2 p R2 p 
 Age, sex, race, and BMI 0.245 0.097 0.339 0.021* 
LI After controlled for covariates 0.004 0.727 <0.001 0.993 
PI After controlled for covariates 0.003 0.760 <0.001 0.966 
PI+II After controlled for covariates 0.029 0.314 0.005 0.652 
EI+II After controlled for covariates 0.016 0.458 0.006 0.619 
EII After controlled for covariates 0.015 0.478 0.020 0.379 
*p<0.05, n=33. Abbreviations: BMI (body mass index), LI (complex I supported leak 
respiration), PI (complex I supported OXPHOS respiration), PI+II (complex I+II supported 
OXPHOS respiration), EI+II (maximal electron transfer capacity with substrates for complex I 
and II), and EII (electron transfer capacity with substrates for complex II only). 
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3.4.3 Group comparison for high and low mitochondrial function 
Our preliminary results showed that some of the dependent variables did not have a linear 
association with mitochondrial respiration. Moreover, although this study was designed to have 
80% power to detect associations between measures of sarcopenia and mitochondrial respiration 
in 40 individuals, for many of the outcome variables these associations were tested in a lower 
number of subjects. Therefore, in addition to investigating the association between mitochondrial 
respiration and measures of sarcopenia using multiple linear regressions, we opted to further 
explore these associations using group comparisons. The results of mitochondrial respiration (PI+II) 
were ranked and split into tertiles. Subjects in the lowest (n=11) and highest tertiles (n=11) were 
compared for myofiber cross-sectional area, intramyocellular lipid content, and physical function.  
No differences in myofiber cross-sectional area (p>0.05, Figure 13A), intramyocellular 
lipid content (p>0.05, Figure 13B), and knee extension torque (p>0.05, Figure 14) were found 
between the low and high mitochondrial respiration groups. While we also observed no differences 
between groups for the multiple chair stand (p>0.05, Figure 15A) and standing balance tests 
(p>0.05, Figure 15B), we found that the high mitochondrial respiration group had a greater gait 
speed on both the 6-meter walk test (p<0.05, Figure 16) and the 20-meter walk test (p<0.05, Figure 
17A). The group comparison also confirmed the results of the multiple linear regression that 
subjects with higher mitochondrial respiration have higher BMI (p<0.05, Figure 18 and 19). 
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Figure 13. Myofiber cross-sectional and intramyocellular lipid content in Low and High mitochondrial 
respiration groups. 
(A) Myofiber cross-sectional area. (B) Intramyocellular lipid content. Data presented as 
Mean and SD; n=11 per group. 
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Figure 14. Knee extension torque in Low and High mitochondrial respiration groups. 
Data presented as Mean and SD, n=8 per group. 
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Figure 15. Multiple chair stand and standing balance tests in Low and High mitochondrial respiration 
groups. 
(A) Time to complete the multiple chair stand test (sec), n=10 for the Low tertile group, and 
n=8 for the High tertile group. (B) Standing balance tests including semi-tandem, tandem and 
one-leg stand (sec), n=10-11 per group. Data presented as Mean and SD.  
 
 
 
 
90 
 
Figure 16. Gait speed on the 6-meter walk test in Low and High mitochondrial respiration groups. 
(A) Gait speed on the 6-meter walk test; n=9 for Low tertile group, and n=10 for the High tertile 
group. (B) Gait speed on the 6-meter walk test; n=3 for Low tertile group, and n=6 for the High 
tertile group. Data presented as Mean and SD; *p<0.05. 
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Figure 17. Gait speed on the 20-meter walk test in Low and High mitochondrial respiration groups. 
(A) Gait speed on the 20-meter walk test, usual pace. (B) Gait speed on the 20-meter walk test, 
fast pace. Data presented as Mean and SD; *p<0.05, n=11 per group. 
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Figure 18. Bivariate correlation between mitochondrial respiration and BMI. 
 
 
 
 Figure 19. Body mass index in Low and High mitochondrial respiration groups. 
Data presented as Mean and SD; *p<0.05, n=11 per group. 
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3.5 DISCUSSION 
Sarcopenia is a public health concern, and may lead to loss of independence, frailty, disability, 
institutionalization and mortality. While several factors have been associated with its onset and 
progression, little is known about the contribution of mitochondrial capacity to the age-related loss 
of muscle mass and strength. In the present study we investigated the influence of mitochondrial 
respiration on measures of sarcopenia in a group of 41 very old individuals (85-95years). While 
mitochondrial respiration did not explain a significant amount of variation in myofiber cross-
sectional area and intramyocellular lipid content, it demonstrated to be associated with grip 
strength, knee extension peak torque, and preferred gait speed. 
Recent data from animal studies have strongly suggested that there is a mechanistic link 
between mitochondria and sarcopenia. During muscle wasting, apoptotic and necrotic muscle 
fibers have shown to exhibit electron transport chain abnormalities, and it is suggested that 
mitochondrial dysfunction is a major contributor to the activation of cell death pathways in aged 
muscle fibers (144). Skeletal muscle of old mice have reduced association between calcium release 
units and mitochondria when compared to young mice, which contributes to impaired cross-talk 
between the two organelles and result in reduced efficiency in ATP production and muscle 
performance (36). Additionally, muscle-specific Atg 7 knockout mice, a model in which skeletal 
muscle lacks a crucial autophagy gene, have shown to present not only abnormal mitochondria, 
but also profound muscle atrophy and decreased strength (19). While these studies have provided 
evidence that muscle mass and function are compromised with mitochondria dysfunction, others 
have demonstrated that improvements in mitochondrial capacity results in diminished loss of 
muscle mass and function. Mice overexpressing PGC-1α, a major regulator of mitochondrial 
biogenesis, have preserved mitochondrial function and reduced muscle wasting with aging (20). 
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Loss of muscle mass in these animals are prevented by reduced apoptosis, autophagy, and 
proteasome degradation (20). Additionally, old animals treated with a mitochondria-targeted ROS 
and electron scavenger demonstrate improved activity of respiratory complexes, reduced protein 
oxidation and higher muscle contractility (37).  
Despite the large number of animal studies supporting the potential link between 
mitochondria and sarcopenia, few human studies have been performed to test this association and 
to investigate the mechanisms involved on these processes (14, 18, 22, 62). Mitochondrial-
mediated apoptotic signaling is increased in muscle from older individuals, with an accumulation 
of dysfunctional mitochondria due to impaired mitophagy (62). Additionally, skeletal muscle of 
older subjects present increased mitochondrial protein carbonyl abundance, which have 
demonstrated to be negatively correlated with muscle strength (149). Other recent cross-sectional 
human studies have suggested that decreased mitochondrial function is associated with lower 
muscle mass, strength and/or poor physical performance. When compared to a group of active 
older adults, it was found that sedentary older adults have a reduced mitochondrial capacity, as 
well as a decreased fat-free mass, declined maximal isometric torque, poorer performance on the 
walk test and stair-climb test (18). Likewise, mitochondrial respiration is reduced in low-
functioning elderly, determined by the short physical performance battery (SPPB) score, when 
compared to high-functioning elderly (14). Additionally, an association between PGC-1α and gait 
speed was observed in these elderly subjects. Similarly, previous study conducted by our research 
group demonstrated an association between mitochondrial efficiency and preferred walking speed 
in a group of older adults (22). However, no studies to date have investigated these associations in 
a group of very older adults, and utilized a comprehensive approach to evaluate physical function.  
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In the present study we evaluated the association of mitochondrial function with muscle 
size at the cellular level. The association of mitochondrial respiration with type I, IIa, and IIx 
myofiber cross-sectional area was tested after controlling for age, sex, race, and BMI. We found 
that after controlling for these covariates mitochondrial respiration do not explain a significant 
amount of variation in myofiber area. Considering that muscle size is not the only factor that 
influences muscle strength and function, we also investigated the quality of these myofibers. No 
association between mitochondrial respiration with intramyocellular lipid content in type I, IIa and 
IIx myofibers was found.  
While no associations were observed between mitochondrial respiration and lipid content 
at the cellular level, we found that BMI was positively associated with maximal OXPHOS. This 
finding is in contrast with other studies that have reported a negative correlation between 
mitochondrial respiration and BMI (17), and with the results of chapter 2 of this dissertation. This 
result may suggest that while having a higher BMI may be detrimental for young and older adults 
and increase the likelihood of several chronic diseases, at very old age it may be beneficial or 
protective. Future analysis will be performed to investigate the contribution of fat free mass and 
fat mass to the BMI of these very older adults, and will be essential to further understand the 
association between BMI with mitochondrial respiration in different age populations. 
In addition to examining the influence of mitochondrial respiration on myofiber cross-
sectional area and intramyocellular lipid content, we also investigated whether mitochondrial 
respiration translates to physical function, including muscle strength, balance and physical 
performance. We found that mitochondrial respiration explained a significant additional amount 
of variation in grip strength, and knee extension torque, after controlled for covariates. 
Additionally, we found that subjects with higher preferred walking speed have higher level of 
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mitochondrial respiration. Considering that these measurements are strong predictors of overall 
health and mortality (150), these findings may also support an essential role of mitochondria for 
overall health status. The results of this study are in agreement with other cross-sectional studies 
that tested the same associations (14, 18, 22). However, these previous studies were conducted in 
younger older adults, and had an age average of 70 to 78yrs. The present study was conducted in 
slightly older subjects (88.5±2.4), and included a total of 10 individuals that were older than 90yrs. 
This may suggest that even after very old age, when several neurological changes occur, 
mitochondrial function may still have an essential role on physical function.  
We acknowledge that multiple comparisons were performed in this study in order to 
investigate the association between mitochondrial respiration (5 respiratory states) and myofiber 
cross-sectional area (4 outcome measures), intramyocellular lipid content (4 outcome measures), 
and physical function (total of 10 outcome measures). However, we opted to not statistically 
control for multiple comparisons due to the exploratory nature of the study. 
3.5.1 Limitations 
This is the first study to investigate mitochondrial respiration of permeabilized myofibers in a 
group of very old individuals. Despite recruiting 41 subjects to be part of this study, some of the 
physical function outcomes were only collected in a subset of the study population. Therefore, the 
sample size was relatively low for the number of associations tested. We addressed this issue by 
further investigating the association of mitochondrial respiration and measures of sarcopenia with 
group comparisons for the subjects in the higher and lower tertiles for mitochondrial respiration. 
However, future studies that include a larger sample are desired.  
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Another limitation of the study was that the population included was very homogeneous in 
terms of general health. We hypothesized that there would be more heterogeneity in mitochondrial 
capacity and physical function in these very old subjects. Future research that include a more 
heterogeneous population with pronounced physical function limitations would provide essential 
information on the association between mitochondrial function and sarcopenia. Additionally, in 
this study we were limited to investigate mitochondrial function by analysis of mitochondrial 
respiration. Futures studies that include a more comprehensive analysis of mitochondrial capacity, 
such as information on mitochondrial content, quality control, and production of reactive oxygen 
species are desired.  
Moreover, we only investigated the influence of mitochondrial respiration on muscle mass 
and quality at the cellular level. Future studies that investigate the association of mitochondrial 
capacity and the whole muscle cross-sectional area are essential. Additionally, analysis of muscle 
quality including measures of intramuscular fat are required. Finally, the development of 
longitudinal studies that examine whether changes in muscle mass, and physical function are 
linked with changes in mitochondrial function is an essential step to establish the influence of 
mitochondria on sarcopenia.  
3.6 CONCLUSION 
Skeletal muscle mitochondrial respiration is associated with physical function at very old age. 
Future studies that incorporate additional measures of mitochondrial capacity and utilizes a 
longitudinal design should be performed, and will provide essential information on the role of 
mitochondrial function in sarcopenia. 
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4.0  SIGNIFICANCE AND DIRECTION OF FUTURE RESEARCH 
Sarcopenia is a major public health concern as life expectancy continues to increase. The condition 
is a well-establish risk factor for several negative health-related conditions such as disability, 
frailty, institutionalization, and mortality (23). While numerous factors have been associated with 
the onset and development of sarcopenia, the primary mechanisms contributing to this process are 
still uncertain. Among the intramuscular factors hypothesized to play a determinant role on skeletal 
muscle aging is mitochondria. Elucidating the specific role of mitochondria on the age-related loss 
of muscle mass and function may assist in the development of preventive approaches and 
therapeutic interventions for sarcopenia, and improve quality of life in the older population. 
In study 1 of this dissertation we investigated whether mitochondrial respiratory capacity 
and quality control are affected with chronological aging. Considering that aging is usually 
associated with decreased physical activity and higher adiposity, we also examined the influence 
of BMI and cardiorespiratory fitness on these associations. While age-related mitochondrial 
dysfunction has been a topic of investigation for several decades, results are contradictory and 
several questions remain to be elucidated. Our study was unique as included a group of 68 subjects 
with a wide range of age, BMI and cardiorespiratory fitness. Additionally, it examined changes in 
mitochondrial quality control with chronological aging, a topic investigated only in a limited 
number of human studies.  
Our findings showed that cardiorespiratory fitness and BMI are more influential to 
mitochondrial capacity than age per se. While we observed no decreases in maximal mitochondrial 
respiration with chronological age, we found that both BMI and cardiorespiratory fitness play a 
significant role on this association. The findings of this study support the idea that improvements 
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in lifestyle, such as increased physical activity and better nutrition could benefit individuals by 
preventing decreases in mitochondrial respiration and alterations in mitochondrial quality control. 
Future longitudinal studies focusing on the lifelong effect of physical activity and body 
composition on mitochondrial function would be crucial to further investigate our findings. 
Additionally, future investigations on the topic should include additional measures of 
mitochondrial function, such as reactive oxygen species generation, ATP production, capacity for 
calcium uptake and others, to provide a more comprehensive understanding of mitochondrial 
capacity in aging.  
In study 2 of this dissertation we investigated the association of mitochondrial function 
with sarcopenia. While several animal studies have provided strong evidence that there is a 
mechanistic link between mitochondrial function and loss of mass and strength (19-21), few 
studies have examined these associations in humans (14, 22). Study 2 was conducted to investigate 
the association between mitochondrial respiration and myofiber cross-sectional area, 
intramyocellular lipid content, and physical function in very old individuals. A cohort of very old 
subjects was selected because at this age decreases in muscle mass and physical function are 
pronounced and associations with mitochondria more likely to be established.  
While we found no association between mitochondrial respiration and myofiber cross-
sectional area and intramyocellular lipid content, mitochondrial respiration was associated with 
grip strength, knee extension torque and preferred gait speed, predictors of overall health and 
mortality. This is the first study, to our knowledge, that investigates mitochondrial respiration of 
permeabilized myofibers in a group of very old individuals. We were limited to evaluate the 
influence of mitochondrial respiration on muscle size and lipid content at the cellular level only. 
Future studies investigating these associations in the whole muscle cross-sectional area and quality 
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will complement the findings of this study, and provide a more comprehensive understanding of 
the influence of mitochondrial function to muscle mass. Additionally, studies with a longitudinal 
design should be performed to determine whether changes in muscle mass, strength and physical 
performance are linked with changes in mitochondrial function. 
The results of this dissertation study provide a better understanding of the association 
between mitochondrial capacity and chronological aging, the age-related changes in mitochondrial 
quality control, the influence of cardiorespiratory fitness and BMI on mitochondrial capacity, and 
the association between mitochondrial function with muscle size, muscle function and physical 
performance.  
We acknowledge that this dissertation study has limitations, such as the research design 
utilized (cross-sectional versus longitudinal) and different inclusion and exclusion criteria for each 
parent study. It would be extremely relevant to be able to compare mitochondrial capacity between 
the old group (Study#1 of this dissertation) and very old group (Study #2 of this dissertation). 
However, we were limited since we didn’t have many common variables between them, such as 
cardiorespiratory fitness and measures of physical function.  
The influence of mitochondrial function on measures of sarcopenia will be further 
investigated using additional data collected for the Health ABC study (study 2 of this dissertation). 
Analysis of whole muscle cross-sectional area as well as muscle quality acquired with computed 
tomography (CT) scan will be used to classify subjects with and without sarcopenia, and further 
investigate the association of mitochondrial function with the age-related loss of muscle mass and 
function. Moreover, additional measures of mitochondrial function, including mitochondrial 
content, ROS production, and expression of proteins that mediate mitochondrial fusion, fission 
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and autophagy will be evaluated to provide a more comprehensive analysis of mitochondrial 
capacity.  
The translational initiative utilized in this dissertation study is an essential step to establish 
the possible role of mitochondria on age-related decreases in muscle mass and function, and it is 
the basis for the development of preventive approaches and effective rehabilitation for sarcopenia. 
The findings of this study contributes to the clinical field by providing evidence that physical 
activity and dietary habits play an essential role on mitochondrial capacity and physical function. 
Understanding the specific role of mitochondria on skeletal muscle aging will allow the 
development of rehabilitation that target the mitochondria.  
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